3 25 Q C 1F C102

9:00 25Q-am01
1, Nirin UDOMSOM1, Emelda ROHANI1, 2, 11 , 2 DNA
9:12 25Q-am02
1,2, 2,3, 1,2, 1
1 , 2 , 3
9:24 25Q-am03 CghA
1, 1, 1, 1, 1, 1, 11
9:36 25Q-am04 Cyclopenin viridicatin
1, 1, 1, 1, 1, 1, 1, 11

9:48 25Q-am05
1, 2, 11 , 2
10:00 25Q-am06 isoprenyl
tryptophan synthase 1, 1, 1, 1
1
10:12 25Q-am07S
1, 1, 1, 1, 11
10:24 25Q-am08
1, 1, 1, 1, 11

10:36 25Q-am09
1, 1, 1, 2, 3, 2, 11 , 2 , 3
10:48 25Q-am10 α -
X 1, 1, 1, 1, 1, 2, 2, 11 , 2KEK
11:00 25Q-am11
1, 1,2, 1, 11 , 2
11:12 25Q-am12S himeic acid
A himeic acid C 1, 1, 1, 2, 2, 11 , 2
11:24 25Q-am13 Aspergillus japonicus MF275
himeic acid 1, 1, 2, 2, 11 , 2
3 25 Q C 1F C102

13:15 25Q-pm01S
13:27 25Q-pm02
1, 2, 3,2, 4, 2, 2, 5, 5, 2
1 , 2 , 3 , 4 , 5
13:39 25Q-pm03S Wnt rocaglamide
1, 1, 1, 1, 1, 11
13:51 25Q-pm04
1, 2, 2, 2, 11 , 2
14:03 25Q-pm05 U
1, 1, 2, 1, 1, 1, 3, 2, 2, 11 , 2 , 3
14:15 25Q-pm06 transrepression PPARγ
1, 1, 2, 1, 11 , 2

14:27 25Q-pm07 vIII
1, 1, 1, 1, 1, 1, 1, 2, 1, 11 , 2
14:39 25Q-pm08S Hippo TAZ
1, 1, 1, 2, 2, 2, 11 , 2
14:51 25Q-pm09 HDAC6
1, 1, 2, 2, 1, 11 , 2
15:03 25Q-pm10S FOP scopranone A
1, 1, 1, 1, 1, 1, 11
15:15 25Q-pm11S
Aβ 1, 1, 1, 1, 1, 1, 11

– 70 –

15:27 25Q-pm12 C5-curcuminoid
1, 1, 1, 1, 2, 11 , 2

15:39 25Q-pm13
1, 1, 1, 1
1
15:51 25Q-pm14
1, 1, 11
16:03 25Q-pm15 Part 29;
piperidine 1, 1, 1, 1, 11
16:15 25Q-pm16 CXCR7
1, 1, 1, 1, 1, 11
16:27 25Q-pm17S KPU-300
1, 1, 1, 2, 1, 1, 1, 2, 11 , 2
3 25 R C 1F C105

9:00 25R-am01
pH 1, 1, 1, 1, 11
9:12 25R-am02S C60
1, 1, 1, 2, 11 , 2
9:24 25R-am03
1, 1, 1, 2, 11 , 2
9:36 25R-am04S Activatable
1,2, 3,4, 1,4, 1, 3, 3, 1,2,31 , 2AMED CREST, 3 , 4JST
9:48 25R-am05S -
1, 1,3, 1,2,41 , 2 , 3JST , 4AMED CREST
10:00 25R-am06S
1,4, 2,3, 1,2,41 , 2 , 3JST , 4AMED CREST

10:12 25R-am07S
1, 1,2, 1,2, 1,2
1 , 2ERATO
10:24 25R-am08S SynCAc
1, 1,2, 1,2, 1,2, 1, 3, 3, 3, 1,2, 1,2, 1,21 , 2JST- ERATO, 3
10:36 25R-am09S
1, 1,2, 1,2, 1,2, 1,2, 3, 3, 1,2, 1,2, 1,21 , 2JST-ERATO, 3
10:48 25R-am10
1,2, 1,2, 1,2, 1, 1,2, 3, 4, 4, 4, 4, 1,2, 1,2
1 , 2JST-ERATO, 3Schrodinger K. K., 4
11:00 25R-am11
1,2, 1,2, 1,2, 1,2, 1,2, 1,21 , 2JST-ERATO
11:12 25R-am12 Wnt/beta-catenin
1, 1, 1, 1, 11
11:24 25R-am13S S-
1,2, 1, 1, 1, 3, 4, 4, 5, 5, 2, 11 , 2 , 3 WPI-ITbM, 4 , 5
3 25 R C 1F C105

13:15 25R-pm01S
1, 1, 1, 1, 11
13:27 25R-pm02S L17E
1, 1, 11
13:39 25R-pm03
1, 1, 11
13:51 25R-pm04
click 1, 2, 1, 1, 11 , 2
14:03 25R-pm05S
1, 1, 1, 11
14:15 25R-pm06S Vibrioferrin
1, 2, 1, Sangita KARANJIT1, 11 , 2

14:27 25R-pm07S Q
1, 1, 1, 1, 1, 11
– 71 –
14:39 25R-pm08S
1, 1, 1, 1, 11
14:51 25R-pm09S c-Src SH2
1,2, 1, 3, 3, 3, 1, 1, 11 , 2 , 3
15:03 25R-pm10
1, 1, 1, 1, 11
15:15 25R-pm11S
1, 1, 1,2, 1, 1,2, 1, 1,21 , 2ERATO-JST
15:27 25R-pm12S
1, 1,2, 1,2, 1,2, 1,21 , 2JST-ERATO

15:39 25R-pm13 PPARγ
1, 1, 1, 2, 2, 2, 11 , 2
15:51 25R-pm14S 25 D SREBP-SCAP
1,2, 2, 2, 3, 2,41 , 2 , 3 , 4
16:03 25R-pm15 What does a complete quantum mechanical
binding analysis of dipeptidyl peptidase IV with antidiabetic drugs conclude? Arulmozhiraja SUNDARAM1,2, Naoya MATSUO1, Seiji OKAZAKI1,2, Hitoshi SHIMANO3,4, Hiroaki TOKIWA1,2,41Department of Chemistry, Rikkyo University, 2Research Center for Smart Molecules, Rikkyo University, 3Department of Internal Medicine (Endocrinology and Metabolism), University of Tsukuba, 4AMED-CREST
16:15 25R-pm16 HIV BMMP
1, 1, 1, 1, 2, 1, 1, 31 , 2 , 3
16:27 25R-pm17
1, 1, 11
3 25 S C 1F C106
-1 N-
9:00 25S-am01S (+)-haplophytine
1, 1, 11
9:12 25S-am02S Iboga Voacangine
1, 1, 1, 1, 11
9:24 25S-am03S Akuammiline
Strictamine 1, 1, 1, 1, 11
9:36 25S-am04S andranginine
1, 1, 1, 1, 11
9:48 25S-am05 Chippiine Dippinine B
1, 2, 1, 11 , 2
10:00 25S-am06S (+)-Lapidilectine B
1, 2, 2, 3, 3, 21 , 2 , 3
-2 N-
10:12 25S-am07S Batzelladine
1, 1, 1, 1
1
10:24 25S-am08S
1, 1, 11
10:36 25S-am09S C H
1, 1, 11
10:48 25S-am10 Alstofolinine B
1, 1, 11
11:00 25S-am11S Pd
(-)-Aurantionclavine 1, 1, 11
11:12 25S-am12S Dictyodendrin
1, 1, 1, 1, 11
11:24 25S-am13S [3+3]
1, 11
3 25 S C 1F C106
-3 N-
13:15 25S-pm01S UCS1025A
1, 1, 1, 11
13:27 25S-pm02S GKK1032A2
1, 1, 1, 11
13:39 25S-pm03
13:51 25S-pm04
1, 1, 1, 2, 3, 11 , 2 , 3
14:03 25S-pm05 TAN1251C
1, 1, 1, 1, 1, 1, 1, 2, 11 , 2
– 72 –

14:15 25S-pm06 (+)-Sieboldine A
Mohammed K. ABD EL-GABER1, 1, 1, 11
-4 N-
14:27 25S-pm07 LycopodiumLycopodine
1, 1, 1, 1
1
14:39 25S-pm08
1, 1, 1, 1, 11
14:51 25S-pm09S (-)-Tetrodotoxin
1, 1, 11
15:03 25S-pm10S
1, 1, 11
15:15 25S-pm11 Calyciphylline F
1, 1, 3, 1, 2, 11 , 2 , 3
15:27 25S-pm12 Palau'amine
1, 1,2, 1, 3, 11 , 2 , 3
-5 N-
15:39 25S-pm13S Plakinidine D
1, 1, 1, 2, 11 , 2
15:51 25S-pm14S Discorhabdin V
1, 1, 11
16:03 25S-pm15S (-)-
1, 1, 11
16:15 25S-pm16S Aconitine C/D
1, 1, 11
3 25 T C 2F C201

9:00 25T-am01 3-( )
1, 1, 1, 1, 1, 11
9:12 25T-am02S
1, 2, 2, 1, 1, 11 , 2JNC
9:24 25T-am03
1, 1, 1, 11
9:36 25T-am04S
1, 1, 1,21 , 2
9:48 25T-am05S
1, 1, 11
10:00 25T-am06S
1, 1, 1, 1
1
10:12 25T-am07
1, 1, 11
10:24 25T-am08
1, 1, 1, 1
1
10:36 25T-am09
1, 1, 1, 1, 11
10:48 25T-am10S σ -
1, 1, 1, 1, 11
11:00 25T-am11S
1, 2,4, 2,3, 1, 2,3,41 , 2JST ERATO, 3WPI-AIMR, 4
11:12 25T-am12S
1, 1, 1, 1
1
11:24 25T-am13 C(sp2)-H
1, 1, 1, 11
3 25 T C 2F C201

13:15 25T-pm01S 2,4,6- -tert - O-
N- 1, 11
13:27 25T-pm02
1, 1, 1, 1
1
13:39 25T-pm03S
1, 1, 1,5, 1, 2,4, 3, 3,4, 3, 1,51 , 2 , 3 , 4ACT-C, JST, 5JST-ERATO
13:51 25T-pm04 σ - -1,n-
Harisadhan GHOSH1, 11
14:03 25T-pm05 Friedel-Crafts
1, 1, 11

14:15 25T-pm06S Pd
1, 1, 11
14:27 25T-pm07S
1, 1, 11
– 73 –
14:39 25T-pm08
1, 2, 2, 31 , 2 , 3
14:51 25T-pm09S
1, 1, 1, 1, 1, 11
15:03 25T-pm10S
1, 1, 1, 1
1
rearrangement reactions of 4,4-disubstituted 2-hydroxycyclohexa-2,5-dieneones into ortho- fluorophenols Ahmed ABUBAKR1, 1, 1, 11

15:27 25T-pm12S
1, 1, 1, 1
1
15:39 25T-pm13S
1, 2, 11 , 2
15:51 25T-pm14S
1, 1, 11
16:03 25T-pm15 C-O
1, 2, 1, 1
1 , 2
16:15 25T-pm16 Activation and stabilization of Pd nanoclusters
for reaction under milder conditions Sangita KARANJIT1, 1, 1, 11
3 25 U C 2F C202

9:00 25U-am01S
1, 1, 1,21 , 2
9:12 25U-am02
1, 1, 2, 1,2
1 , 2
9:24 25U-am03S
1, 1, 1, 1, 1, 11
9:36 25U-am04
3(2H)- 1, 1, 1, 1, 1, 1, 2, 2, 1
1 , 2
9:48 25U-am05 1,3-
1, 1, 1,21 , 2JST- ERATO
10:00 25U-am06S
1, 1, 11

10:12 25U-am07
1, 2, 3, Dennis P. CURRAN41 , 2 , 3 , 4
10:24 25U-am08
1, 1, 1, 1
1
10:36 25U-am09S
1, 1, 1, 1, 11
10:48 25U-am10S one-pot
1, 1, 1, 1, 11
11:00 25U-am11
1, 1, 1, 1, 11
11:12 25U-am12
1, 1, 1, 11
11:24 25U-am13 Nd/Na 2
1, 1, 11
3 25 U C 2F C202
N-
13:15 25U-pm01S α -
1, 1, 1, 1, 11
13:27 25U-pm02S BINOL
α - Friedel-Crafts 1, 1, 1, 1, 1, 11
13:39 25U-pm03
Zijian LIU1, Toshifumi TAKEUCHI1, Roman Krzysztof PLUTA1, Fernando Arteaga ARTEAGA1, Naoya KUMAGAI1, Masakatsu SHIBASAKI11
13:51 25U-pm04S
14:03 25U-pm05
1, 1, 11
14:15 25U-pm06
Iodocarbocyclization 1, 1, 11
– 74 –
N-
14:27 25U-pm07
1, 1, 1, 1, 1, 11
14:39 25U-pm08S
1, 1, 1, 1
1
1, 1, 11
15:03 25U-pm10S [4+3]
1, 1, 1, Sangita KARANJIT1, 11
15:15 25U-pm11S o-
1, 1, 11
15:27 25U-pm12S Cu(II)-Naph-diPIM-dioxo-iPr
Friedel-Crafts 1, Phuc Thien LE1, 2, 3, 11 , 2 , 3
N-
15:39 25U-pm13
Pyrrolo[2,3-c]carbazole 1, 1, 1, 1, 11
15:51 25U-pm14 N -
1, 1, 1, 1, 1, 1, 1, 11
16:03 25U-pm15
1, 1, 1, 11
16:15 25U-pm16 3,6-
1, 1, 1, 1, 11
16:27 25U-pm17S S-
1, 1, 1, 1
1

9:00 26Q-am01S Lamellodysidea
herbacea 1, 1, 1, 1
1
9:12 26Q-am02 Aspergillus taichungensis
1, 1, 1, 1, 11
9:24 26Q-am03 Quassinoids: Viral Protein R Inhibitors from
Picrasma javanica Bark Collected in Myanmar Nwet Nwet WIN1,2, Takuya ITO1, Takeshi KODAMA1, Yi Yi WIN2, Hla NGWE2, Hiroyuki MORITA11Division of Natural Products Chemistry, Institute of Natural Medicine, University of Toyama, 2Department of Chemistry, University of Yangon, Myanmar
9:36 26Q-am04 New diterpenoids from Plectranthus
scutellarioides collected in Indonesia Kartika SENDA1, Takuya ITO1, Hiroyuki MORITA11

9:48 26Q-am05
1, Qin LI2, 3, 11 , 2 , 3
10:00 26Q-am06 Carapa guianensis
1, 1, 1, 1, 1, 2, 2, 2, 11 , 2
10:12 26Q-am07 Artabotrys siamensis
1, 1, 1, 2, 11 , 2
10:24 26Q-am08S Callicarpa mollis
Leishmania 1, 1, 1, 2, 11 , 2

10:36 26Q-am09S
1, 1, 1, 2, 11 , 2
10:48 26Q-am10S BF-0158 amphotericin B
1, 1, 11
11:00 26Q-am11 3
1, 1, 11
11:12 26Q-am12S Mincle
Huy LE VAN1, 1, 2, 1
1 , 2
11:24 26Q-am13
phosphatidylethanolamine 1, 1, 2, 1
1 , 2

13:15 26Q-pm01
1, 1, 2, 11 , 2
13:27 26Q-pm02S Sciadopitysin
1, 1, 1, 1, 1, 1, 11
– 75 –
Banzragchgarav ORKHON1, Kyoko KOBAYASHI1, Batkhuu JAVZAN2, Sasaki KENROH11 , 2
13:51 26Q-pm04
1, 2, 1,3, 3, 1,3,4, 2, 1,3,41 , 2 , 3 , 4

14:03 26Q-pm05S
BALB/c C57BL/6 1, 2, 1,2,3, 2, 2, 1,2,31 , 2 , 3
14:15 26Q-pm06 TRPV1 Zingiber officinale
1,2, 1,2, 1,2, 1, 1,2, 1,2, 1,2, 1, 1, 3, 3, 4, 1,21 , 2 , 3 , 4
14:27 26Q-pm07 K562
1, 1, 1, 1, 2, 2, 2, 31 , 2 , 3
14:39 26Q-pm08 Polymethoxyflavonol
"natsudaidain" 1,2, 2, 1, 3
1 , 2 , 3

14:51 26Q-pm09 (3)
1, 1, 1, 1, 1, 2, 2, 2, 1
1 , 2
15:03 26Q-pm10 Glycyrrhiza glabra
1, 1, Inoyat FATTOKHOV2, Madibron SAIDOV21 , 2
15:15 26Q-pm11
1, 1, 1, 1
1
15:27 26Q-pm12
1, 2, 1, 1, 11 , 2

15:39 26Q-pm13 DI-EI-MS
T (ATL) 1, 1, 2, 1, 3, 4, 5, 2, 2, 11 , 2 , 3 , 4 , 5
15:51 26Q-pm14 NMR
1, 1, 1, 2, 11 , 2
16:03 26Q-pm15S
1, 1, 1, 2, 2, 2, 11 , 2UHA
16:15 26Q-pm16S
KAKI CALYX 1, 2, 2, 1, 1, 2, 1,3, 1,3
1 , 2 , 3
16:27 26Q-pm17 PERSICAE SEMEN
1, 1, 1, 1,2, 3, 1,21 , 2 , 3
3 26 R C 1F C105

9:00 26R-am01S Activatable HClO
1, 1, 4, 4, 1,2,31 , 2 , 3AMED CREST, 4
9:12 26R-am02S SNAP-tag activatable
1,4, 2,3, 1,2,41 , 2 , 3JST , 4AMED CREST
9:24 26R-am03S In vivo pH
1, 1, 1,2,31 , 2 , 3AMED CREST
9:36 26R-am04
1, 1,2, 1, 1,2, 1, 3, 11 , 2 , 3 21
9:48 26R-am05S TALE
1, 1, 11
10:00 26R-am06S RNARNA
1, 1, 11

10:12 26R-am07
1, 1,5, 4,5, 4, 4, 1,2,31 , 2 , 3AMED CREST, 4 , 5JST PRESTO
10:24 26R-am08S
1, 1, 1,4, 2,4, 3, 3, 3, 1,2,51 , 2 , 3 , 4JST , 5AMED CREST
10:36 26R-am09S P450 P450BM3
1, 1, 1, 1, 1, 11
– 76 –
10:48 26R-am10 N-Sulfanylethylanilide
1, 1, 1, 1, 1,2, 1, 11 , 2JST
11:00 26R-am11S
1, 1, 1, 1, 1, 11
11:12 26R-am12 activatable -
1, 1, 1,2,31 , 2 , 3AMED CREST
11:24 26R-am13S His
1,2, 2, 2, 2, 2, 2, 21 , 2
3 26 R C 1F C105

13:15 26R-pm01
BNCT 1, 1, 1, 1,2, 2, 2, 11 BNCT , 2
13:27 26R-pm02S
1, 1, 1, 2,4, 3, 2, 2,4, 1, 11 , 2 , 3 , 4
13:39 26R-pm03 DMSO
1, 1, 11
13:51 26R-pm04 fragment-based drug design
1, 1, 1, 1
1
14:03 26R-pm05
EGFR 1, 1, 1, 1, 1, 11
14:15 26R-pm06 β
1,2, 1,2,3, 1, 1, 1, 1,2, 1,2, 1,21 , 2JST-ERATO, 3

14:27 26R-pm07
1, 2, 11 , 2
14:39 26R-pm08
1, 1, 1, 1, 11
14:51 26R-pm09S
1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 11
15:03 26R-pm10S AB
1, 1, 1, 2, 1, 11 , 2
15:15 26R-pm11S
dual inhibitor 1, 1, 1, 1, 11

15:27 26R-pm12 SAXS-MDD
1, 1, 2, 3, 1, 1, 31 , 2 , 3
15:39 26R-pm13S D
1, 1, 1, 1, 1, 11
15:51 26R-pm14 HDAC2
1, 1, 1, Alexander VAN DER WIEL1, 11
16:03 26R-pm15 N+-C-H...O
1, 11
16:15 26R-pm16 Potent Mechanism-Based Sirtuin 2-Selective
Inhibition by an in Situ Generated Occupant of Selectivity Pocket, Substrate-Binding Site, and NAD+-Bindig Pocket. Paolo MELLINI1, 1, 2, 1, 1, 3, 4, 2, 3, Maija LAHTELA-KAKKONEN5, 11 , 2 , 3 , 4 , 5
3 26 S C 1F C106
-6
9:00 26S-am01
1, 1, 2, 1, 1, 2, 1, 11 , 2
9:12 26S-am02S
1, 1, 11
9:24 26S-am03
1, 1, 11
9:36 26S-am04 Arenicolide A 26
1, 1, 1, 1, 1, 11
9:48 26S-am05S
1, 1, 1, 1, 1, 2, 3, 11 , 2 , 3
– 77 –
1, 1, 11
-7
10:12 26S-am07S Cotylenin A
1, 1, 1, 11
10:24 26S-am08S
1, 1, 1, 11
10:36 26S-am09S
1, 1, 1, 1, 11
10:48 26S-am10 (+)-Ascospiroketal B
1, 1, 1, 1
1
11:00 26S-am11S
1, 1, 1, 1, 2, 2, 21 , 2
11:12 26S-am12S 1,3-
A 1, 2, 2, 2, 21 , 2
11:24 26S-am13 1
1, 1, 1, 1
1

13:15 26S-pm01S α , β -
1, 1, 11
13:27 26S-pm02
1, 1, 11
13:39 26S-pm03S Melleolide
1, 1, 1, 1
1
13:51 26S-pm04S 4 π trans-
1, 2, 1, 1
1 , 2
14:03 26S-pm05S
1, 1, 2, 2, 2, 2, 21 , 2
14:15 26S-pm06 4-epi -Parvifloron
1, 1, 1, 2, 1,21 , 2

14:27 26S-pm07 3
1,2, 1, 1, 1,31 , 2 , 3JST-ERATO
14:39 26S-pm08 coriariin A
1, 1, 1, 1, 11
14:51 26S-pm09
1, 1, 11
15:03 26S-pm10S
1, 2, 1, 21 , 2
15:15 26S-pm11S ‘Catch & Release’
1, 1, 1, 1
1
15:27 26S-pm12S siRNA
1, 1, 1, 1
1
15:39 26S-pm13S 4’- RNA
1, 1, 1, 1
1

9:00 26T-am01
1, 1, 11
9:12 26T-am02S AZADO/Cu
1, 1, 1, 1
1
9:24 26T-am03S
C(sp3)-H 1, 1, 1, 1,2
1 , 2JST-ERATO
9:36 26T-am04 sp3 C-H
1, 1, 1,21 , 2JST ERATO
9:48 26T-am05S
α 1, 1, 1, 1
1
10:00 26T-am06 -
1, 1, 1, 1
1
10:12 26T-am07
1, 1, 1, 1, 11

10:24 26T-am08 C(sp3)-H
10:36 26T-am09 α - - γ -
1, 1, 11
– 78 –

10:48 26T-am10S α -ketiminoester
Mannich 1, 1, 11
11:00 26T-am11S N
1, 1, 11
11:12 26T-am12 α - -7-
1, 1, Weidner KARIN1, 1, 11
11:24 26T-am13S β -
1, 1, 1, 1, 11
3 26 T C 2F C201

13:15 26T-pm01S
1, 1, 2, 1
1 , 2
13:27 26T-pm02S N-
1, 1, 1,2, 1, 1,21 , 2
13:39 26T-pm03
1,2, 2, 2, 2, 1,21 , 2
13:51 26T-pm04S π - NHC
1, 1, 1,21 , 2JST-ERATO
14:03 26T-pm05 /
1, 1, 1, 1, 1,21 , 2JST-ERATO
14:15 26T-pm06 1,3-
1, 1, 1, 1, 1, 1, 11

14:27 26T-pm07 0
1,3- 1, 1, 1, 1
1
14:39 26T-pm08S
1, 1, 1, 1, 11
14:51 26T-pm09
1, 1, 1,21 , 2JST-ERATO
15:03 26T-pm10 NHCα -
1,2, 2, 2, 1
1 , 2
15:27 26T-pm12
1, 1, 1, 1, 11

15:39 26T-pm13 C-
1, 1, 2, 1, 1
1 , 2
15:51 26T-pm14S
1, 1, 11
16:03 26T-pm15 N-
1, 1, 1, 11
16:15 26T-pm16S
1, 1, 1, 1
1
16:27 26T-pm17S
1, 2,3, 3, 3, 2, 4, 1,2,3, 2,3,5
1 , 2 , 3 , 4 , 5
3 26 U C 2F C202

9:00 26U-am01 α -Cl Br
Mannich 1, Pandur Venkatesan BALAJI1, 1, 11
9:12 26U-am02 α
1, 1, 1, 1
1
9:24 26U-am03
1, 1, 1,2, 1
1 , 2
9:36 26U-am04
1, 1,2, 1, 1
1 , 2
9:48 26U-am05S MnO2α -
1, 1, 1, 1, 11
10:00 26U-am06S SEAlide
on-resin 1, 1, 1, 1, 1, 11
10:12 26U-am07S
1, 1, 1, 1, 11
– 79 –

10:24 26U-am08S DMAP
1, 2,3, 1, 1, 1, 2,3, 11 , 2 , 3JST-ERATO
10:36 26U-am09
1, 1, 1,21 , 2JST-ERATO
10:48 26U-am10S α
1, 1, 2, 1, 11 , 2
11:00 26U-am11
PBB3 1, 1, 1, 1, 11
11:12 26U-am12S
1, 1, 11
11:24 26U-am13
1, 1, 1, 2, 2, 2, 1, 1, 11 , 2
3 26 U C 2F C202
N-
13:15 26U-pm01
1, 1, 1, 1, 11
13:27 26U-pm02 Ni α -C(sp3)-H
1, 1, 11
13:39 26U-pm03S 5-
ε 1, 1, 1, 1, 1, 11
13:51 26U-pm04
- / 1, 1, 11
14:03 26U-pm05
1, 1, 1, 1, 11
14:15 26U-pm06
Kornblum-DeLaMare 1, 11
N-
14:27 26U-pm07S γ -
1, 1, 1, 11
14:39 26U-pm08S CF3
1, 1, 11
14:51 26U-pm09S B(C6F5)3
/ 1, 1, 1, 1
1
15:03 26U-pm10
1, 1, 1, 1, 11
15:15 26U-pm11
1, 2, 1, 3, 11 , 2 , 3
N-
15:27 26U-pm12S
1, 2, 1, 1, 1, 1, 1, 11 , 2
15:39 26U-pm13S 3-
1, 1, 1, 1, 11
15:51 26U-pm14S
1, 1, 1, 1, 11
16:03 26U-pm15S
1, 1, 1, 1, 11
16:15 26U-pm16S
1, 1, 1, 1
1
16:27 26U-pm17 C(sp3)-H
1, 1, 1, 1
1

9:00 26V-am01 NHC-Cu
1, 1, 11
9:12 26V-am02 Cu/Pd α -CF3
α - 1, 1, 11
9:24 26V-am03
1, 1, 11
9:36 26V-am04S
1, 1, 11
9:48 26V-am05S
1, 1, 1, 11
– 80 –
10:00 26V-am06S C-H
1, 1, 2, 1,3, 1,31 , 2 , 3ERATO-JST

10:12 26V-am07S
C(sp3)-H 1, 1, 11
10:24 26V-am08S C(sp3)-H
1, 1, 1, 11
10:36 26V-am09S
1, 2, 3, 3, 2, 1, 11 , 2 , 3 JASRI
10:48 26V-am10
gem- 1, 1, 1, 11 CLST
11:00 26V-am11S [2+2+2]
1, 1, 1, 1, 1, 1, 11
11:12 26V-am12S C-O / C-N
C-C 1, 1,2, 1,21, 2
11:24 26V-am13
1, 1, 1,21 CLST, 2
3 26 V C 2F C205

13:15 26V-pm01S
1, 1, Kumar SARVENDRA1, 1, 2, 2, 1,31 , 2 , 3
13:27 26V-pm02S β
1, 1, 1, 1
1
13:39 26V-pm03 β
1, 1,2, 1, 3, 1,2, 1,2, 1,21, 2 , 3
13:51 26V-pm04
1, 2, 1, 3, 3, 31 , 2 , 3
14:03 26V-pm05S BINAN-Py-PPh-Ru
1, 2, 3, 1
1 , 2 , 3
14:15 26V-pm06
. α- 1, 1, 11
-8 N
14:27 26V-pm07 Rh C-H
parthenolide 1, 1, 1, 11
14:39 26V-pm08 -MN
- 1, 2, 11 , 2
14:51 26V-pm09 Leptolyngbyolide C
1, 1, 11
15:03 26V-pm10S
lissoclinolide 1, 1, 11
15:15 26V-pm11S 3
Avenaol 1, 1, 1, 1
1
15:27 26V-pm12 Dendrochrysanene
1, 1, 2, 3, 2, 11 , 2 , 3
-9
15:39 26V-pm13S SNAr /Claisen
1, 1, 1, 1, 1, 11
15:51 26V-pm14 -
tomentonone 1, 1, 1, 1, 11
16:03 26V-pm15S
1, 1, 1, 11
16:15 26V-pm16 Ullmann
1, 1, 1, 1, 11
16:27 26V-pm17S (-) Cinanthrenol A
1, 1, 1, 1, 11
3 27 Q C 1F C102

9:00 27Q-am01 Feijoa sellowiana Berg
4 C- 1, 11
9:12 27Q-am02 Artocarpus comunnis
1, 1, 1, 1
1
– 81 –
9:24 27Q-am03S Brachanthemum gobicum
Batsukh ODONBAYAR1, 1, Javzan BATKHUU2, 11 , 2
9:36 27Q-am04S Hypericum (45)
H. pseudohenryi phenylketide- shortketide , pseudoherin A-E 1, 1, 11

9:48 27Q-am05S (Nigella damascena )
oxazonigelladine damasterpene I, II 1, 1, 1, 1, 1, 1, 1, 11
10:00 27Q-am06S
1, 1, 1, 1
1
10:12 27Q-am07S
ππ 1, 1, 1, 11
10:24 27Q-am08S
1, 2, 2, 1, 3, 11 , 2 , 3

10:36 27Q-am09S
1, 1, 1, 1, 1, 1, 1, 11
10:48 27Q-am10 AGEs
1, 1, 1, 1, 2, 11 , 2
11:00 27Q-am11S SOAT2
1, 1, 1, 1, 11
11:12 27Q-am12S
1, 1, 11
3 27 Q C 1F C102

13:15 27Q-pm01S Ophiorrhiza nutans
ON16 1, 1, 1, SANTIARWORN DAMMRONG2, 11 , 2Chaing Mai
13:27 27Q-pm02S
- 1, Chin Piow WONG1, 1, 2, 11 , 2
13:39 27Q-pm03 Berberine Sphingobium sp. BD3100
palmatine 1, 1, 1, 1, 2, 2, 3, 11 , 2 , 3
13:51 27Q-pm04
1, 1, 11

14:03 27Q-pm05S
1, 2, 1, 2, 21 , 2
14:15 27Q-pm06 An anti-mycobacterial sphingolipid and a new
bromopyrrol alkaloid from an unidentified Indonesian marine sponge Delfly B. ABDJUL1,2, Hiroyuki YAMAZAKI1, Syu-ichi KANNO1, Ayako TOMIZAWA1, Henki ROTINSULU2,3, Defny S. WEWENGKANG2, Deiske A. SUMILAT2, Kazuyo UKAI1, Magie M. KAPOJOS3, Michio NAMIKOSHI11Tohoku Medical and Pharmaceutical University, 2Sam Ratulangi University, 3University of Pembangunan Indonesia
14:27 27Q-pm07S Structures and biological activities of alkyl
pyridinium alkaloids from an unidentified Indonesian marine sponge Wilmar MAARISIT1,2, Delfly B. ABDJUL1,2, Hiroyuki YAMAZAKI1, Hajime KATO1, Henki ROTINSULU2,3, Defny S. WEWENGKANG2, Deiske A. SUMILAT2, Kazuyo UKAI1, Magie M. KAPOJOS3, Michio NAMIKOSHI11Tohoku Medical and Pharmaceutical University, 2Sam Ratulangi University, 3University of Pembangunan Indonesia

14:39 27Q-pm08S
1, 1, 1, 1,2
1 , 2JST-ERATO
14:51 27Q-pm09S μ
1, 1, 1, 1, 11
15:03 27Q-pm10 RXFP
1, Akhter HOSSAIN2, Ross BATHGATE2, 2, 1, John WADE1
1 , 2
15:15 27Q-pm11 PETRXR
CBt-PMN 1, 1, 1, 1, 2, 2, 2, 2, 3, 11 , 2 OMIC, 3
15:27 27Q-pm12S 300
1, 1,2,3, 1, 1, 1,2, 1, 1, 4, 2, 2, 1,2,31 , 2 , 3 , 4
– 82 –
3 27 R C 1F C105

9:00 27R-am01S (II)
1, 1, 2, 11 , 2
9:12 27R-am02 ROS
1, 1, 1, 1
1
9:24 27R-am03S GSTP1
1, 1, 1, 1, 1, 11
9:36 27R-am04
In vivo 1, 2, 1,3, 4, 4, 1,3, 41 , 2 , 3AMED-CREST, 4
9:48 27R-am05
1,2, 1,2, 1,2, 1,2
1 , 2AMED-CREST
10:00 27R-am06 Turn-ON
1,2, 1,2, 1,2, 1,2
1 , 2AMED-CREST
10:12 27R-am07
HIV 1, 2, 1, 1, 3, 3, 3, 3, 4, 5, 11 , 2 , 3 , 4 , 5
10:24 27R-am08 Zn2+/pDNA
1, 1, 11
10:36 27R-am09
SARS 3CL 1, 1, 1, 1, 1, 2, 11 , 2
10:48 27R-am10S E2
1, 1, 1, 1, 1, 1, 1, 1, 1
1
11:00 27R-am11S
1, 2, 1, 1, 1, 1, 1, 1, 1
1 , 2
11:12 27R-am12 Apratoxin A
1,2, 1,3, 1, 1
1 , 2 , 3

13:15 27R-pm01
N-sulfanylethylaminooxybutyramide (SEAoxy) 1, 1, 1, 2, 1, 2, 11 , 2
13:27 27R-pm02S β
1, 1, 1, 1,2, 1, 1,21 , 2ERATO-JST
13:39 27R-pm03S
1, 1, 1, 1, 1, 2, 1, SANGITA KARANJIT1, 11 , 2
13:51 27R-pm04S N-
1, 1, 2, 1, 1, 2, 11 , 2
14:03 27R-pm05S (+)-cylindricine C
1, 1, 2, 1, 11 , 2
14:15 27R-pm06 one-pot
1, 1, 11

14:27 27R-pm07S B
1, 1, 11
14:39 27R-pm08S B
1, 1, 1, 1
1
1, 1, 11
15:03 27R-pm10 - Leucinostatin A
1, 1, 1, 1, 11
15:15 27R-pm11 Piperidamycin F
1, 1, 1, 2, 11 , 2
15:27 27R-pm12 JBIR-126
1, 1, 2, 1
1 , 2
15:39 27R-pm13 Coibamide A
1, 1, 1, Kerry L. MCPHAIL2, 1, 1, 1
1 , 2
15:51 27R-pm14
neodysiherbaine A 1, 1, 1, 1, 1, 1, 1, 11
– 83 –
16:03 27R-pm15S B :
1, 1, 2, 2, 2, 11 , 2
16:15 27R-pm16S WAP-8294A2
1, 1, 11
3 27 S C 1F C106

9:00 27S-am01 1-[6]
1, 1, 1, 1, 2, 11 , 2
9:12 27S-am02S
; 1,2, 1,2, 3, 3, 2, 1,21 , 2 , 3
9:24 27S-am03S
1, 1,2, 11 , 2
9:36 27S-am04
1, 1, 1, 1
1
9:48 27S-am05S (2+2)
1, 1, 1, 1, 1, 2, 2, 11 , 2 , 3
10:00 27S-am06S (2+2)
1, 2, Arulmozhiraja SUNDARAM1,3, Sladek VLADIMIR1,3, 1, 2, 2, 2, 2, 2, 1,31 , 2 , 3
-10
10:12 27S-am07S Tunicamycin
10:24 27S-am08S Nannocystin Ax
1, 11
10:36 27S-am09S Actinoallolide A
1, 1,2, 1,2, 1, 1, 1,2, 1,2, 2, 1,21 , 2
10:48 27S-am10S Mangromicin A
1, 1,2, 1,2, 1, 2, 2, 2, 1,21 , 2
11:00 27S-am11 ;
1, 1,2, 1,2, 1, 1, 1, 2, 1,21 , 2
11:12 27S-am12S Eurotiumide
1, 1, 1, 1
1
-11
13:15 27S-pm01 Daphniyunnine D
1, 1, 1, 1, 11
13:27 27S-pm02S Daphniyunnine
1, 1, 1, 1
1
1, 1, 11
13:51 27S-pm04S
1, 1, 1, 1, 1, 2, 3, 1, 11 , 2 , 3
14:03 27S-pm05 AB
1, 1, 1, 11
14:15 27S-pm06S
1, 1, 1, 1, 11
-12
14:27 27S-pm07S niizalactam C
1, 1, 11
14:39 27S-pm08S
8-deoxyheronamide C 1, 1, 1, 11
14:51 27S-pm09S A
1, 1, 1, 11
15:03 27S-pm10
1, 1, 1, 1
1
15:27 27S-pm12S
1, 1, 11
-13
15:39 27S-pm13
1, 1, 11
15:51 27S-pm14S
1, 1, 11
16:03 27S-pm15S
1, 1, 11
16:15 27S-pm16S H
1, 1, 1, 1, 1, 2, 1, 3, 1
1 , 2 , 3
16:27 27S-pm17
1, 1, 1, 1, 2, 3, 11 , 2 , 3
– 84 –
3 27 T C 2F C201
N-
9:00 27T-am01S
1, 1, 1, 11
9:12 27T-am02
[3+3] 1,2,3, 1, 3, 1,2, 1,2, 1,2, 31 , 2 , 3
9:24 27T-am03
1,4- 1, 1, 2, 1
1 , 2
9:36 27T-am04 N
1, 1, 1, 1, 11
9:48 27T-am05
1, 1, 1, 1
1
10:00 27T-am06S
/ 1, 1, 1, 1
1
10:12 27T-am07 2H-azirine
1, 1, 11
10:24 27T-am08 4
1, 1, 1, 1
1
10:36 27T-am09S A βC-H
1, 1, 1,2, 1,2, 1,21 , 2JST-ERATO
10:48 27T-am10S
1, 1, 1, 1, 1, 11
11:00 27T-am11S
1, 1, 1, 1
1
11:12 27T-am12 In(OTf)3-BHAα , β -
7-1,3- 1, 1, 11
11:24 27T-am13 -
HIV 1, 1, 11
3 27 T C 2F C201
N-
13:15 27T-pm01 α
1, 1, 1, 1, 11
13:27 27T-pm02S Joullie-Ugi
1, 1, 11
13:39 27T-pm03
1, 1, 1, 1
1
13:51 27T-pm04S O-
1, 1,2, 1, 1
1 , 2
14:03 27T-pm05
Chris OPIE1, 1, 11
14:15 27T-pm06S N
1, 1, 1, 1, 1, 1, 11

14:27 27T-pm07
1, 1, 1, 1, 2, 11 , 2
14:39 27T-pm08
1,2, 2, 1, 1, 1, 2, 11 , 2
14:51 27T-pm09S ABPX
1, 1,2, 1,21 , 2 CLST
15:03 27T-pm10S
1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 11 , 2
15:15 27T-pm11S
1, 1, 1, 2, 2,3, 2,3, 1,21 , 2 , 3
15:27 27T-pm12S 3,3' BINOLCAr-O
1, 1, 1, 11

15:39 27T-pm13 [12]CPP
1, 1, 2, 1,3, 2, 11 , 2 , 3
15:51 27T-pm14S N - -N-(2- )
1, 1, 1, 1, 11
– 85 –
16:03 27T-pm15
1,2, 1, 3, 3, 2, 1,21 , 2 , 3
16:15 27T-pm16
1, 1, 11
16:27 27T-pm17 (
) 1, 1, 1, 1, 11
3 27 U C 2F C202

9:00 27U-am01 RNA
1, 1, 1, 1,2, 1,2,31 , 2 , 3
9:12 27U-am02
1, 1, 1, 11
9:24 27U-am03S DNA
1, 1, 11
9:36 27U-am04S 8-oxo-dGTP
1, 1, 11
9:48 27U-am05S 3 DNA CG
1, 1, 1, 11
10:00 27U-am06
- 1, 1, 1, 11
10:12 27U-am07S siRNA
RNAi 1, 1, 1, 1, 11

10:24 27U-am08S 9-( )
BNAP-AEO 1,2, 1,2, 1,21 , 2CREST-JST
10:36 27U-am09S scpBNA-2-
1, 1, 11
10:48 27U-am10S hMTH1 dGTP
1, 1, 1, 11
11:00 27U-am11S 3 DNATA
1, 1, 1, 1
1
11:12 27U-am12S RNA
1, 1, 1, 1, 11
11:24 27U-am13 3’-5’ tRNA
1, 1, 11
3 27 U C 2F C202

13:15 27U-pm01S
1, 1, 1, 11
13:27 27U-pm02
13:39 27U-pm03 7-
1, 11
13:51 27U-pm04S BlNA :
χ 1, 2, 11 , 2
– 86 –
3 25 P C 1F C101
HPLC-
9:00 25P-am01S HPLCNANA
ADOA 6 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 11
9:12 25P-am02S Study of reaction between 4-fluoro-7-nitro-2,1,3-
benzoxadiazole (NBD-F) and tertiary amines by LC-MS Xiaomin LI1, Yayoi KANBAYASHI2, Zekun YANG1, Muneki ISOKAWA1, Chao WANG1,3, Takashi FUNATSU1, Masanobu UCHIYAMA1,3, Makoto TSUNODA11Graduate School of Pharmaceutical Sciences, The University of Tokyo, 2Institute of Innovation, Ajinomoto Co., Inc., 3Riken
9:24 25P-am03 DOXIL
1, 2, 1, 31 , 2 , 3
9:36 25P-am04 HPLC-ECD
3-HPMA 1, 1, 1, 1,2, 1,2, 11 , 2
9:48 25P-am05S
1, 2, 1, 1,2, 3, 3, 3, 1,2
1 , 2 , 3
10:00 25P-am06S
1, 1, 11
LC-MS
10:12 25P-am07S :
1, 1, 1, 11
10:24 25P-am08S II
LC/ESI-MS 1, 1, 1, 11
10:36 25P-am09 LC-MS ADP
1, 1, 1, 2, 2, 1, 1, 1
1 , 2
10:48 25P-am10 HILIC LC-MS/MS
NMDA 1, 2, 2, 2, 1,2, 1,21 , 2
11:00 25P-am11S LC-ECD-ESI-MS
1, 1, 1, 1, 11
11:12 25P-am12S SimSpectraST
1, 1, Veronika SUNI2, 1
1 , 2
11:24 25P-am13 MALDI/TOF-MS(/MS)
1, 1, 1, 2, 3, 11 , 2 , 3
3 25 P C 1F C101
HPLC-
13:15 25P-pm01 HPLC
1, 1, 1, 1, 1,2, 2, 11 , 2
13:27 25P-pm02 -
HPLC 1, 1, 1, 1,2, 2, 1, 11 , 2
13:39 25P-pm03
HPLC 1, 1, 1, 1, 1, 1,2, 2, 11 , 2
13:51 25P-pm04 HPLC-MS/MS
D- 1, 1, 2, 2, 1, 11 , 2
14:03 25P-pm05 NBD
HPLC 1, 1, 1, 1, 1, 2, 11 , 2

14:15 25P-pm06
SSJ-183 1, 1, 1, 1, 1, 11
14:27 25P-pm07
1, 1, 1, 1, 11
14:39 25P-pm08 IV
1, 1, 1, 2
1 , 2
14:51 25P-pm09S ANA/BTG3 (Catalytide)
- β 1, 1, 1, 1, 2, 2, 11 , 2OIST
15:03 25P-pm10 C
Cu2+ 1,2, 3, 3, 3, 3, 1, 1, 31 , 2 , 3

– 87 –

15:15 25P-pm11
1, 2, 3, 2, 2, 1, 1, 21 , 2 , 3 AT
15:27 25P-pm12S
1, 1, 1, 1, 11
15:39 25P-pm13S
1, 1, 1, 1
1
15:51 25P-pm14S
1, 1, 2, 11 , 2
16:03 25P-pm15S
piperonyl acetone 1, 1, 1, 1
1
16:15 25P-pm16S
Piribedil 1, 1, 11
3 26 P C 1F C101

9:00 26P-am01
1, 2, 2, 21 HBS( ), 2
9:12 26P-am02S
1, 1, 11
9:24 26P-am03S
1,2, 1,2, 1,2, 3, 4,5, 4,5, 2, 6, 11 , 2 , 3 , 4 , 5 , 6
9:36 26P-am04S AFM
1,2, 1,2, 1, 3, 1,21 , 2 , 3
9:48 26P-am05S
1,2, 3, 3, 4, 3, 4, 2, 5, 11 , 2 , 3 , 4 BNCT, 5
10:00 26P-am06S magainin 2
1, 1, 11

10:12 26P-am07S Development of stealth shell based on
polycarboxybetaine structure tuned to selectively interact with cells in tumor extracellular acidic pH Abdul-Hackam RANNEH1, 1, 1, 1, 1, 11
10:24 26P-am08
Selenenenylsulfide (-Se-S-) 1, 1, 2, 1, 11 , 2
10:36 26P-am09
1, 1, 1, 2, 3, 11 , 2 , 3
10:48 26P-am10S PEG
1, 1, 1, 1, 1, 2, 3, Kenneth J. SHEA2, 11 , 2 , 3
11:00 26P-am11
1,2, 2, 2, 2
1 , 2
11:12 26P-am12
1, 1,2, 1, 1, 1, 1,21 , 2 DDS
11:24 26P-am13S
1, 1, 1, 1
1

13:15 26P-pm01S
1, 1, 1, 1
1
13:27 26P-pm02
1, 1, 1, 1
1
13:39 26P-pm03 Epalrestat Caffeine
1, Okky D PUTRA2, 1, 1, 1, 1, 2, 1
1 , 2
13:51 26P-pm04 Meloxicam Coamorphous
1, 1, 1, 1
1
14:03 26P-pm05 X CT
1, 1, 11
– 88 –
14:15 26P-pm06 X
1, 1, 1, 2, 11 , 2

14:27 26P-pm07 NMR
Dvl 1, 1,3, 2, 2, 2, 2, 3, 3, 1,31 , 2 , 3
14:39 26P-pm08 D- β -Asp NMR
1, 11
14:51 26P-pm09 NMR
1,2, 1,2, 1, 1,2
1 , 2
15:03 26P-pm10
1, 1, 1, 1, 11
15:15 26P-pm11S ALS H46R SOD1
1, 1, 1, 1
1
15:27 26P-pm12
1, 1, 1, 11

15:39 26P-pm13
1, 1, 1, 1, 2, 31 , 2 , 3
15:51 26P-pm14S C60 Li +@C60
β 1, 1, 1, 2, 3, 11 , 2 , 3
16:03 26P-pm15S
1, 2, 2, 2,3
1 , 2 , 3JST
16:15 26P-pm16
1, 1, 2, 3, 11 , 2 , 3
16:27 26P-pm17
1,2, 3, 3, 4, 1,2, 1,5, 1, 6, 4, 3,7, 1,2,81 , 2 , 3 , 4 , 5 , 6 , 7JST-ACCEL, 8AMED-CREST
3 27 P C 1F C101

9:00 27P-am01S Hydroxymethyl Rhodamine
1, 2,3, 4, 4, 1,2,51 , 2 , 3JST , 4 , 5AMED CREST
9:12 27P-am02S BODIPY
1, 1,3, 1,2,41 , 2 , 3JST , 4AMED CREST
9:24 27P-am03S
1,4, 2,5, 1, 1, 3, 3, 1,2,41 , 2 , 3 , 4AMED CREST, 5JST
9:36 27P-am04S
Ca2+ 1,3, 1, 1, 1, 1,2,31 , 2 , 3AMED CREST
9:48 27P-am05S (JoSai-Red)
1, 1, 1, 1
1
10:00 27P-am06S [123I]IMPY
β 1, 2, 1, 1, 1, 21 , 2

10:12 27P-am07S
1, 1,2,3, 1, 1, 11 , 2 , 3
10:24 27P-am08S SPECT
123I 1, 1, 1, 1, 1, 11
10:36 27P-am09S
1, 1, 1, 1, 1, 1, 1, 2, 1, 11 , 2
10:48 27P-am10S NEXTA18F
1, 1, 1, 1, 2, 1, 3, 4, 11 , 2 , 3 , 4
11:00 27P-am11 99mTc ReRI/
1, 1, 1, 1
1
11:12 27P-am12S Radiotheranostics -IX
1, 1, 1, 1
1
– 89 –
11:24 27P-am13 [18F] HF(F- ) FBPA
1, 2,3, 2, 2,3, 3, 1, 4, 1, 2, 11 , 2 , 3 , 4
3 27 P C 1F C101

13:15 27P-pm01S Legumain in vivo
1, 1, 1, 1, 11
13:27 27P-pm02S 111In-DOTA
1, 1, 1, 1, 1, 1, 11
13:39 27P-pm03S 1 99mTc 6
RGD 1, 1, 1, 11
13:51 27P-pm04S 99mTc 2
1, 1, 1, 1, 1, 11

14:03 27P-pm05S γ
1, 1, 1, 1, 1, 11
14:15 27P-pm06S γTRPV1
1, 1, 1, 1, 1, 1, 11
14:27 27P-pm07
1, 2, 3, 1
1 , 2 , 3
14:39 27P-pm08S
1, 1, 1, 11
14:51 27P-pm09 THz ATR
1, 1, 2, 1, 21 , 2
27P-pm10
3 25 V C 2F C205

9:00 25V-am01 α -
1, Chu-Wei KUO2, 1, 3, Kay-Hooi KHOO2, 1,31 , 2 , 3
9:12 25V-am02S
1, 1, 1, 1, 1, 2, 3, 4, 3, 5, 5, 1, 2, Robert J LINHARDT6, 1,7, 1
1 , 2 , 3 , 4 , 5 , 6 , 7
9:24 25V-am03
1, 1, 1, 1, 11
9:36 25V-am04 TMEM5
β 1,4-xylosyltransferase 1, 2, 3, 3, 4, - 1, 5, 5, 4, 3, 11 , 2 , 3 , 4 , 5

9:48 25V-am05S
1, 1, 1, 1, 1, 1, 2, 2, 1
1 , 2
10:00 25V-am06S GM3
1, 1, 1, 1, 2, 2, 2, 11 , 2
10:12 25V-am07S CTSA
1, 2, 1, 1, 3, 4, 4, 2, 3,4, 1,21 , 2 , 3 , 4

10:24 25V-am08 LPLAT
1, 3, 3, 1,2
1 , 2AMED- CREAT, 3
10:36 25V-am09
1, 1, 1, 1, 1, 11
10:48 25V-am10 GPAT3
1, Yuqian LUO2, 2, 1, 1, 1, 1, 11 , 2
11:00 25V-am11 CoA 4
1,2, 1, 11 , 2
11:12 25V-am12 LDL
I-123 1,2, 2, 2, 3,2, 2, 2, 4,2, 4,2, 2, 4,2, 21 , 2 , 3 , 4
11:24 25V-am13S GPCRMRGX4
1, 1,2, 1, 1,3
1 , 2JST, 3AMEDAMED- CREST
3 25 V C 2F C205

13:15 25V-pm01S
PHGPx E 1, 1, 11
13:27 25V-pm02S Tay-Sachs iPS
1, 1,2,3, 1, 1, 1,2,31 , 2 , 3AMED,ACT-M
13:39 25V-pm03S
1, 1, 11
13:51 25V-pm04
1,2,3, 2, 3, 1,2,3
1 , 2 , 3
14:03 25V-pm05S PAF
1, 1, 1,2, 1,3
1 , 2PRIME, AMED, 3AMED-CREST
14:15 25V-pm06S
1, 1, 1, 2, 1,2,31 , 2 , 3AMED-CREST
14:27 25V-pm07
IL-10 1, 1, 1, 11
14:39 25V-pm08S ATX-LPAVE-cadherin
1, 1, 1,2, 1,3
1 , 2 , 3AMED
– 91 –
14:51 25V-pm09 ATX-LPA
1, 1, 1, 2, 1,31 , 2 , 3AMED-CREST

15:03 25V-pm10S PA-PLA1a LPA6
1, 1, 1,2, 1,3
1 , 2JST, 3AMED-CREST
15:15 25V-pm11 LPA6
1, 1, 11
15:27 25V-pm12S
1, 1, 1,2, 1,2, 1,2, 3, 3, 4, 1,2
1 , 2AMED-CREST, 3 , 4
15:39 25V-pm13S
1, 1, 11

15:51 25V-pm14S
LysoPS 1, 1, 1, 1, 1,21 , 2AMED- CREST
16:03 25V-pm15S T
1, 1, 2, 1
1 , 2
16:15 25V-pm16 (PGIS)
1, 1, 2, 1
1 , 2
16:27 25V-pm17
IP 1, 1, 1, 1, 1, 1, 1,2, 3, 1,21 , 2AMED-CREST, 3
3 25 W C 2F C206

9:00 25W-am01 TNF- α NF- κ B
Robo4 1, 1, 1, William C AIRD2, 1, 11 , 2
9:12 25W-am02S TEA domain transcription factor
1, 1, 1, 1, 1, 1, 11
9:24 25W-am03 IFIH1MDA5)
1, 1, 1, 1, 21 , 2
9:36 25W-am04 LXRα FSP27
1, 1, 1, 2, 11 , 2
9:48 25W-am05S p300/GATA4 WDR5/
MLL1 1, 1, 1,2,3, 1,2,3, 2, 2, 2, 1,2,3
1 , 2 , 3
10:00 25W-am06
1, 1, 1, 1
1
10:12 25W-am07S GATA4 C
ZF 1, 1, 1,2,3, 1,2,3, 2, 2, 1,2,31 , 2 , 3
10:24 25W-am08S TET1
1, 1, Jeremia FEBRIAN1, 2, 1, 11 , 2
10:36 25W-am09S NERDNAEXO1
1, 1, 1, 11
10:48 25W-am10S DNA
1, 1, 1, 1, 1, 1, 11
3 25 W C 2F C206

13:15 25W-pm01S c-Abl zinc finger
1, 1, 1, 1, 1, 1, 11
13:27 25W-pm02S RACK1
1,2, 1, 1,2,3, 1,2,3, 1,2, 2, 2, 1,2,3
1 , 2 , 3 25W-pm03
13:39 25W-pm04 pVHLB-Myb HIF α
VHL 1, 1, Byrne STUART D.1, 1, ( ) 1, 4, 3, 2, 1, 11 , 2 , 3 , 4
– 92 –
13:51 25W-pm05
1, 1, 11

14:03 25W-pm06 USP28 Snail
1, 1, 1, 2, 11 , 2
14:15 25W-pm07 CBX2
1, 1,2, 1, 1, Ashutosh KUMAR1, Kam Y.J. ZHANG1, 2, 11 , 2
14:27 25W-pm08 TRAF6
1, 1, 2, 2, 3, 3, 3, 1, 21 , 2 , 3
14:39 25W-pm09S A
1, 2, 2,3, 2,3, 1, 1, 4, 3, 11 , 2 , 3 , 4
14:51 25W-pm10S
1, 1, 1, 1, 11
RNA
15:03 25W-pm11 (17 α ,20E)-
17,20-[(1-Methoxyethylidene)bis(oxy)]-3-oxo-19- norpregna-4,20-diene-21-carboxylic Acid Methyl Ester (YK11) AR 1, 1, 1, 1, 11
15:15 25W-pm12 RNA epigenetics RNA
AlkB homolog 8 1, 1, 1, 1, 1, 1, 1, 2, 2, 3, 3, 3, 1,21 , 2 , 3
15:27 25W-pm13S MCPyVNEAT1
1, 2, 3, 3, 1, 1, 1, 1, 3, 11 , 2 , 3
15:39 25W-pm14 YB-1
(YB-NLS) 1, 1, 1, 1, 2, 1, 11 , 2
15:51 25W-pm15
1, 1, 1, 1, 1, 1, 1, 1, 11
3 25 X C 3F C301

9:00 25X-am01S
1, 1, 1, 2, 3, 11 , 2 , 3
9:12 25X-am02
1, 2, 2, 3, 4, 5, 61 , 2 , 3 , 4 , 5 , 6
9:24 25X-am03S
Rac1 signaling 1, 2, 1, 1, 11 , 2
9:36 25X-am04S miR-133a-3p
RhoA/Rho-kinase 1, 1, 2, 2, 11 , 2 3
9:48 25X-am05S
1, 1, 2, 2, 11 , 2 3
10:00 25X-am06S low pH
PGE2 1, 1, 1, 2, 11 , 2

10:12 25X-am07S 2
(ILC2) 2 1, 1, 1, 1, 1, 2, 1,3, 1,3, 1,31 , 2 , 3
10:24 25X-am08S
1, 1, 2, 1, 1, 1, 1, 31 , 2 , 3
10:36 25X-am09S
long noncoding RNAs 1, 1, 1, 1, 2, 2, 31 , 2 3, 3
10:48 25X-am10S
1, 1, 1, 1, 1, 2, 1,2,3, 11 , 2 , 3
11:00 25X-am11 SCIT
IL-10 CD4+ T IL-10 B 1, 1, 1, 2, 21 , 2
– 93 –
11:12 25X-am12
Tr1 1, 1, 1, 1, 1, 11
11:24 25X-am13
CD25 1, 2, 11 , 2
3 25 X C 3F C301

13:15 25X-pm01 IgA
13:27 25X-pm02S ATP Concanavalin A T
1, 1, 11
13:39 25X-pm03S Toll
4 1, 1, 1, 1, 1, 1, 11
13:51 25X-pm04S
1, 1, 1, 1, 11
14:03 25X-pm05S
1, 1, 1, 2, 3, 3, 1, 11 , 2 , 3
14:15 25X-pm06S
1, 1, 1, 1, 1, 1, 1, 1,2, 11 , 2( )

14:27 25X-pm07 2
1, 1, 2, 3, 4, 11 , 2 , 3 , 4
14:39 25X-pm08
1, 1, 11
14:51 25X-pm09
1, 1, 1, 1
1
15:03 25X-pm10
Nrf 1, 1, 1, 1, 11
15:15 25X-pm11
1, 2, 2, 1
1 , 2
15:27 25X-pm12
1, 2, 2, 1, 21 , 2

15:39 25X-pm13 (Aphanothece sacrum)
1, 2, 2, 2, 1, 1, 11 , 2
15:51 25X-pm14S
1, 1, 1, 1, 1,2, 3, 3, 1
1 , 2 , 3
16:03 25X-pm15 TRPM8
1, 1, 1, 1, 11
16:15 25X-pm16 3D
1,2, 1,3, 1, 1, 1, 2, 2, 21 , 2 , 3
16:27 25X-pm17
1, 1, 1, 1, 1, 21 , 2
3 25 Y C 3F C302

9:00 25Y-am01S
1, 1, 1, 1
1
9:12 25Y-am02S
1, 1, 1, 1, 2, 3, 4, 1,5,61 , 2 , 3 , 4 , 5 , 6
9:24 25Y-am03
1, Steven A. CONNOR2, 3, Ammendrup-Johnsen INA2, 3, 1,4, 1, Razib HOSSAIN1, 4, Ann Marie CRAIG21 , 2Univ. British Columbia, 3 , 4
9:36 25Y-am04S EGF
1,2, 1, 2, 1,2
1 , 2
9:48 25Y-am05S
1, 3, 1,2, 1,2, 1,2, 4, 5, 6, 2, 7, 1,21 , 2 , 3NRL , 4 , 5 , 6 , 7
– 94 –
10:00 25Y-am06S
1,2, 1, 1,2, 1, 1, 1, 1, 2, 3, 4, 1,21 , 2 , 3 , 4

10:12 25Y-am07S Zn2+
LTP 1, 1, 1, 1, 1, 11
10:24 25Y-am08S CA3 CA1
Zn2+ 1, 1, 1, 1, 11
10:36 25Y-am09S Zn2+
1, 1, 1, 1, 11
10:48 25Y-am10S AMPA
Ca2+Zn 2+ 1, 1, 1, 1, 11
11:00 25Y-am11S Zn2+Aβ
-Aβ 40 Aβ 42 - 1, 1, 1, 1, 11
11:12 25Y-am12S (central post-stroke pain:
CPSP) NG,NG-dimethylarginine dimethylaminohydrase 1 (DDAH1) 1, 1, 2, 11 , 2
11:24 25Y-am13 β
1, 1, 1, 1, 2, 11 , 2
3 25 Y C 3F C302

13:15 25Y-pm01
1, 2, 1, 1, 1, 1, 3, 3, 1, 2,1, 11 , 2 , 3
13:27 25Y-pm02S sodium-glucose
transporter type 1 c-Jun N-terminal kinase p38 1, 1, 11
13:39 25Y-pm03S
orexin-A 1, 1, 11
13:51 25Y-pm04 PGE2
- 1,2, 2, 2, 2, 3, 4, 2, 2, 2, 21 , 2 , 3 , 4
14:03 25Y-pm05 LDL
thrombospondin-1 1,2, 1, 1, 1, 1, 1, 1, 1, 1, 1,2, 11 , 2
14:15 25Y-pm06 t-PADIC
thrombomodulin 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1
1 , 2 , 3
14:27 25Y-pm07S
1, 1, 1, 1, 1, 11
14:39 25Y-pm08
1, 1, 11
14:51 25Y-pm09
1, 1, 1, 1, 1, 2, 3, 3, 3,4, 3, 3, 3, 11 , 2 , 3 , 4
15:03 25Y-pm10
1, 1, 1, Beverly A. ROTHERMEL2, Eric N. OLSON2, 3, 4, 11 , 2UT Southwestern Med. Cent., Dallas, 3 , 4
15:15 25Y-pm11
1, 1, 1, 1, 11
15:27 25Y-pm12
1, 2,3, 1, 1, 1, 3, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 4, 3, 1,21 , 2 , 3 , 4

15:39 25Y-pm13S
1, 1, 1, 1, 11
15:51 25Y-pm14S
1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1,3, 1, 4, 1, 1,21 , 2 (L-StaR), 3 , 4
16:03 25Y-pm15S
Amyloid- β 1, 1, 1, 1
1
– 95 –
16:15 25Y-pm16 Citrus tachibana
1, 1, 2, 2, 2, 3, 3, 3, 3, 3, 3, 11 , 2 , 3
16:27 25Y-pm17 in vivo
1, 1, 2, 2, 2, 2, 2, 11 , 2
3 26 W C 2F C206

9:00 26W-am01S 4
9:12 26W-am02S
1, 1, 1, 1, 2, 11 , 2
9:24 26W-am03 D-
1, 1, 1, 1, 11
9:36 26W-am04 Atg4B
1, 1, 1, 2, 3, 2, 1, 11 , 2 , 3

9:48 26W-am05 Cysteine 99
9 1, 2, 1, 2, 3,4, 4, 5, 1,61 , 2 , 3 , 4 , 5 , 6
10:00 26W-am06S β Catalytide
1, 2, 1, 1, 3, 3, 11 , 2 , 3OIST
10:12 26W-am07 Tob1 Catalytide
1, 1, 1, 1, 1, 1, 2, 11 , 2OIST
10:24 26W-am08 Cataytide β -
1, 1, 1, 1, 1, 11

10:36 26W-am09S Nobiletin
1, 1,2,4, 1, 1, 1,2, 1,2,4, 3, 2, 2, 1,2,41 , 2 , 3 , 4
10:48 26W-am10S Y030
p300-HAT 1, 1,2, 1, 1,2,3, 1,2,3, 4, 2, 2, 1,2,31 , 2 , 3 , 4
11:00 26W-am11 D
1, 1, 11
11:12 26W-am12
1, 1, 1, 1, 1, 11
3 26 W C 2F C206

13:15 26W-pm01
1, 2, 1, 1, 11 , 2
13:27 26W-pm02 ALKBH6 RNA
1, 1, 1, 1, 1, 1, 1, 11
13:39 26W-pm03
1, 1, 1, 1, 2,3, 11 , 2 , 3
13:51 26W-pm04S eIF2 α
BAG-1 1, 1, 1, 1
1
14:03 26W-pm05 M2PKM2
1, 1, 1, 1, 11

14:15 26W-pm06
1, Cuiying HE1, 21 , 2
14:27 26W-pm07 HIF-1 Hsp105
1, 1, 1, 1, 11
14:39 26W-pm08S RINGMKRN1
1, 1, 1, 1, 11
14:51 26W-pm09 Zn2+
CA1 LTP 1, 1, 1, 1
1
15:03 26W-pm10S Nrf2
1, 1, 1, 1, 11
– 96 –
15:15 26W-pm11S
1, 2,1, 1, 1, 11 , 2

15:27 26W-pm12S TGF- β
1, 1, 1, 1, 1, 1, 11
15:39 26W-pm13S
1, 1, 1, 1, 11
15:51 26W-pm14S Nrf2-ARE
1, 1, 1, 1, 1, 1, 11
16:03 26W-pm15 Ras guanyl releasing protein2 (RASGRP2)
1, 1, 1, 1
1
16:15 26W-pm16
1, 1, 1, 1, 11
16:27 26W-pm17S
1, 1, 1, 1, 1, 1, 1, 11
3 26 X C 3F C301
1
9:00 26X-am01S LPS-binding protein Toll 4
TRIF IKKε /TBK1/IRF3 1, 1, 1, 1, 1, 1, 1, 1
1
9:12 26X-am02S Toll 4Gr1+CD11b+
1, 1, 1, 1, 1, 11
9:24 26X-am03S LysoPS
1, 1, 1,21 , 2AMED-CREST
9:36 26X-am04 T
9:48 26X-am05 NLRP3
1, 1, 11
10:00 26X-am06 MAllograft
inflammatory factor 1 (Aif1) 1,2, 2, 21 , 2
2
10:12 26X-am07S CGRP
1, 1, 1, 1, 1, 1, 11
10:24 26X-am08S 2/3
1,3, 1, 1, 1, 1, 1,2,31 , 2 , 3 MEI
10:36 26X-am09 CAR-T CAR /
1, 1, 1, 1, 1, 11
10:48 26X-am11
1, 1,5, 1, 1, 1, 2,3, 1,2,3, 3,4, 1,2,51 , 2 , 3 , 4 , 5 MEI
11:00 26X-am12 PEGTNF
1,2, 2,3, 2,3,4, 3,4, 1,2,41 , 2 , 3 , 4 MEI
3 26 X C 3F C301
1
13:15 26X-pm01 ADAMTS-3
1, 1, 1, 1, 1, 11
13:27 26X-pm02S ADAMTS
1, 2, 1, 1
1 , 2
13:39 26X-pm03 TREM2-DAP12
1, 1, 1, 1, 1, 11
13:51 26X-pm04S
Neuroligin 4X 1, 1, 1, 1, 11
14:03 26X-pm05 FUS/TLS Ptk2b
1, 1, 1, 1, 1, 11
14:15 26X-pm06S GPR40/FFAR1
1, 1, 11
2 URA
14:27 26X-pm07S
1, 1, 1, 11
– 97 –
14:39 26X-pm08
1,2, 1, 2, 2, 1, 21 , 2
14:51 26X-pm09
1, 1, 1, 1
1
15:03 26X-pm10 BRINP1
1, 1, 1, 1, 2,3, 2, 2, 11 , 2 , 3
15:15 26X-pm11S NBCe1
1, 1, 1, 1, 1, 1, 2, 11 , 2
15:27 26X-pm12S
1,2, 1,2, 1,2, 1,2
1 , 2 TR
15:39 26X-pm13S Wwp1
1, 1, 1, 1,2, 1,21 , 2 TR

15:51 26X-pm14 LPP
SAMP1 1, 1, 1, 1, 2, 2, 2, 1, 3,4,51 , 2 &, 3, 4, 5
16:03 26X-pm15
1,2, 2, 1, 1, 3, 3, 3, 2
1 , 2 , 3
16:15 26X-pm16 C
1,2, 1, 2, 2, 11 , 2
16:27 26X-pm17
3 26 Y C 3F C302

9:00 26Y-am01
morin quercetin 1, 1, 1, 1, 1, 1, 1, 1, 1, 11
9:12 26Y-am02S
ERK1/2 1, 1, 1, 1, 1, 11
9:24 26Y-am03 II
1, 2, 1, 1,2, 2, 1, 1, 1, 1, 1, 1, 1,2
1 , 2
9:36 26Y-am04
1, 2, 2, 2, 1,21 , 2
9:48 26Y-am05S
1, 2, 1, 1, 3, 4, 11 , 2 , 3 , 4
10:00 26Y-am06S
1, 2, 1, 3, 1, 11 , 2 , 3
10:12 26Y-am07S PDE5
1, 1, 2, 3, 1, 2, 1,3,41 , 2 , 3 , 4

10:24 26Y-am08
diphenhydraminefamotidine 1, 1, 11
10:36 26Y-am09S MFG-E8
1, 1, 1, 1, 11
10:48 26Y-am10
1, 1, 1, 1, 1, 1, 1, 11
11:00 26Y-am11S Nobiletin NBP1 ( Nobiletin
Binding Protein1 ) 1, 1,2,3, 1, 1, 1, 1,2,3, 4, 5, 1, 1, 6, 2, 2, 1,2,31 , 2 , 3 , 4 , 5 , 6
11:12 26Y-am12S GATA4
RACK1 1,2, 1, 1,2,3, 1,2,3, 1,2, 2, 2, 1,2,3
1 , 2 , 3
11:24 26Y-am13
1, 1, 1, 1, 1, 2, 3, 11 , 2 , 3
– 98 –
3 26 Y C 3F C302

13:15 26Y-pm01 αPKC
1, 2, 2, 2, 1, 2, 3, 11 , 2 , 3
13:27 26Y-pm02S TRPV2β
1, 1, 11
13:39 26Y-pm03
βδ 1, 1, 1, 1, 1, 1, 11
13:51 26Y-pm04
1, 1, 1, 1, 1, 1, 11
14:03 26Y-pm05
1, Hasita HORLAD1, 1, 1, 1, 1, 11
14:15 26Y-pm06
GPR120/FFAR4 1, 1, 1, 2, 3, 11 , 2 , 3

14:27 26Y-pm07 L6 P2
1, 1, 1, 11
14:39 26Y-pm08 TRPM8
1, 1, 1, 1
1
14:51 26Y-pm09 TRPA1
1, 1, 1, 1
1
15:03 26Y-pm10
-TRPA1 - 1, 1, 1, 1, 2, 11 , 2
15:15 26Y-pm11S
1, 1, 1, 1, 11
3 27 V C 2F C205

9:00 27V-am01 Tic22
2, 3, 4, 1
1 , 2 , 3 , 4
9:12 27V-am02 ABCABCD1
CoA 1, 1, 1, 1, 11
9:24 27V-am03S c-Src LC3
1, 1, 1, 1, 1, 1, 1, 11
9:36 27V-am04S Moesin
1, 1, 1, 1
1
9:48 27V-am05S
1, 1, 1, 1
1
10:00 27V-am06S Src
1, 1, 1, 2, 11 , 2
10:12 27V-am07S
1, 1, 1, 2, 4, 1,31 , 2 , 3 , 4

10:24 27V-am08
(MCU) 1,2, 1,2, 1,2, 3, 1, 4, 1,21 , 2 , 3 , 4
10:36 27V-am09S
1, 1,2,3, 1, 2, 1, 1, 2, 1,2,31 , 2 , 3AMED,ACT-M
10:48 27V-am10S Ni2+ IL-8
1, 1, 11
11:00 27V-am11 ATP13A4
1, 1, 1, 2, 2, 11 , 2
11:12 27V-am12S
1, 1, 1, 1, 1, 1, 11
11:24 27V-am13 DNA damage
1, 1, 1, 1
1
– 99 –
3 27 V C 2F C205

13:15 27V-pm01 Sandhoff
Tfeb 1, 1,2,3,4, 1, 1, Spampanato CARMINE3, Ballabio ANDREA3, 1,2,41 , 2 , 3TIGEM, 4AMED,ACT-M
13:27 27V-pm02S v-Src
1, 1, 1, 1, 1, 1, 1, 1, 1,2, 1, 11 , 2
13:39 27V-pm03S FP003
1, 2, 2, 1, 3, 1,31 , 2 , 3
13:51 27V-pm04S Ca2+
PPARα 1, 1, 1, 1, 1, 11
14:03 27V-pm05S
(1 μM,10 μ M) 1, 1, 1, 1, 1, 11

14:15 27V-pm06S AE2/SLC4A2 IRBIT
pH 1, 1, 1, 1, 1, 1, 1, 2, 3, 11 , 2 , 3
14:27 27V-pm07S EP4PGE
1,2, 2, 3, 2, John W REGAN4, 2, 3, 1
1 , 2 , 3 , 4
14:39 27V-pm08S TGF- β
1, 1, 1, 1, 1, 1, 11
14:51 27V-pm09S TNFGDP/GTP
BIG1 1, 1, 1, 1, 11
15:03 27V-pm10 JAK2V617F TpoR
1, 1, 1, 1
1
15:15 27V-pm11 GPRC5BmTOR
1, 1, 11

15:27 27V-pm12
1, 1, 1, 11
15:39 27V-pm13 FGD1
1, 1, 11
15:51 27V-pm14S Ridaifen-B
1, 1, 2, 2, 3, 2, 1, 11 , 2 , 3
16:03 27V-pm15S
1, 1, 1, 1
1
16:15 27V-pm16 EMTSox4
1, 1, 1, 1, 1, 11
16:27 27V-pm17 FAM83H
1, 1, 2, 11 , 2
3 27 W C 2F C206

9:00 27W-am01 TASK1-TALK2 2
1, 1, 1, 1, 11
9:12 27W-am02S GPCR
1, 1,2,3, 1, 1,4
1 , 2JST, 3AMED PRIME, 4AMED CREST
9:24 27W-am03S Ca2+ Cl -
TMEM16A/B 1, 1, 1, 1, 11
9:36 27W-am04
KCa1.1 1, Anowara KHATUN1, 1, 1, 1, 1, 11
9:48 27W-am05
Ca2+K +K Ca3.1 1, 1, 1, 1, 11
10:00 27W-am06
TMEM16A 1, 1, 1, 1, 11

10:12 27W-am07 CaSR PDE5
1, 1, 1, 1, 11
– 100 –
10:24 27W-am08
OATP2A1 1, 1, 11
10:36 27W-am09 D
KCa1.1 Anowara KHATUN1, 1, 1, 1, 2, 11 , 2
10:48 27W-am10S
1,2, 1,2, 1,2, 1, 3, 1,21 , 2 , 3
11:00 27W-am11S iPS
1, 2, 2, 3,2, 1, 4, 4, 2, 1,21 , 2 , 3 , 4
11:12 27W-am12 iPS in
vitro 1, 1, 11
11:24 27W-am13
1, 1, 1, 11
3 27 W C 2F C206

13:15 27W-pm01S
1, 1, 1, 2, 11 , 2
13:27 27W-pm02S
1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 11 , 2
13:39 27W-pm03S 5-fluorouracil CXCL1
1, 1, 1, 1, 1, 1, 2, 2,3,4, 11 , 2 , 3 , 4
13:51 27W-pm04S
1, 1, 1, 1, 11
14:03 27W-pm05S
1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1,2, 21 , 2

14:15 27W-pm06S
1, 1, 1, 1
1
1, 1, 11
14:39 27W-pm08S
1, 1, 2, 2, 2, 1, 11 , 2
14:51 27W-pm09S GPCR
1, 1,2,3, 1, 1, 1,41, 2 JST, 3AMED-PRIME, 4AMED-CREST
15:03 27W-pm10 AMED
1, 1, 2, 3, 4, 11 , 2 , 3 , 4

15:15 27W-pm11 3-
CYP1 1,2, 1,2, 2, 2, 1,21 , 2
15:27 27W-pm12 AhR
1, 1, 1, 1, 1, 11
15:39 27W-pm13
1, 1, 2, 2, 1, 11 , 2
15:51 27W-pm14 P450 3A1 UDP-
2B3 1, 1, 1, 1, 2, 3, 1, 11 , 2 , 3 , 4
3 27 X C 3F C301

9:00 27X-am01S
1, Arulmozhiraja SUNDARAM1,2, 3, 3, 4, 4, 5, von Itzstein MARK6, 1,21 , 2 , 3 , 4 , 5 , 6Inst. Glycomics Griffith Univ.
9:12 27X-am02
1, 2, 2, 4, von Itzstein MARK3, 1,51 , 2 , 3Inst. Glycomics Griffith Univ., 4 , 5
– 101 –
9:24 27X-am03S
MxA tricin 1, 1, 1, 1, 1, 11
9:36 27X-am04S
1, 1, 1, 1, 11
9:48 27X-am05
1, 1, 1, 2, 1, 3, 3, 11 , 2JRA, 3
10:00 27X-am06S iPS B in
vitro 1, 1, 1, 1,2,3,4, 1, 5, 5, 6, 6, 1,2,71 , 2 , 3 , 4JST , 5 , 6 , 7 MEI

10:12 27X-am07 CCore ER
1, 1, 1, 1
1
10:24 27X-am08 RNA
1, 1,2, 1, 1, 1,3,4,51 , 2 , 3 , 4 MEI , 5
10:36 27X-am09 IgA
1, 1, 2, 2, 11 , 2
10:48 27X-am10S IgA
1, 1, 1, 1, 2, 2, 11 , 2
11:00 27X-am11
1, 1, 1, 1, 2, 2, 11 , 2
11:12 27X-am12S C5
1, 1, 2, 1, 1, 1, 2, 2, 1, 31 , 2 , 3
11:24 27X-am13S SSL5 MMP-9
1, 1, 11
3 27 X C 3F C301

13:15 27X-pm01 Aeromonas sobria
1, 1, 1, 1, 21 , 2
13:27 27X-pm02 ’GReAT’
1, 1, 2, 3, 4, 3, 1, 1, 1, 1, 1, 1, 1, 5, 5, 5, 5, 61 , 2 , 3 , 4 , 5 , 6
13:39 27X-pm03S
1, 1, 1, 1, 11
13:51 27X-pm04S
1, 1, 11
14:03 27X-pm05S
1, 1, 2, 2, 11 , 2
14:15 27X-pm06
1, 2, 2, 1
1 , 2
3 27 E 3F 2

9:00 27E-am01 ORF34
1, 1, 1, 1, 11
9:12 27E-am02S FITC
1, 1, 1, 1, 1, 1, 11
9:24 27E-am03S
1, 1, 1, 1, 1, 1, 11
9:36 27E-am04 (HUVEC)
(PCOOH) 1, 2, 2, 2, 3, 1, 11 , 2 , 3
9:48 27E-am05 LPS
1, 11

10:00 27E-am06S Theaflavin OATP2B1
1, 1, 1, 1, 2, 1,21 , 2
10:12 27E-am07
/ 1,2, 2,1, 3, 4,2,1
1C, 2, 3, 4
10:24 27E-am08S
1, 2, 3, 1
1 , 2 , 3
10:36 27E-am09S MAIDI Biotyper
1, 1, 1,2, 1
1 , 2

9:00 27F-am01
1, 1, 1, 1, 2, 2, 2, Olivier TRANQUET3, Sandra DENERY3, 4, 4, 4, 1, 1, 11 , 2 , 3 , 4
9:12 27F-am02
1, 2, 2, 3, 2, 11 , 2 , 3
9:24 27F-am03S
1, 1, 1, 1, 1, 11
9:36 27F-am04S
1, 1, 1, 1, 2, 2, 1, 1, 1
1 , 2
9:48 27F-am05S
1, 1, 11
10:00 27F-am06 DNA
1, 1, 1, 2, 3,4, 1, 1,51 , 2 , 3 , 4 , 5 MEI

10:12 27F-am07S
1,2,3, 4, 4,5, 2, 2,61 , 2 , 3 DC, 4IR-FEL, 5 , 6
10:24 27F-am08 PM2.5
1, 1, 21 , 2
10:36 27F-am09S
1, 1, 2, 1,3, 31 , 2 , 3
10:48 27F-am10S
1, 1, 2, 3, 4, 4, 21 , 2 , 3 , 4
11:00 27F-am11S
1, 2, 11 , 2
11:12 27F-am12S
1, 1, 1, 1, 1, 1, 1, 1, 1, 11
11:24 27F-am13S
1, 1, 1, 1, 1, 1, 1, 1, 1, 11

– 103 –
3 27 F 3F 8

13:15 27F-pm01 PXR,CAR
PPARαP450 1, 1, 1, 2, 3, 11 , 2 , 3
13:27 27F-pm02 PBDEAhR
UGT 1, 2, 2, 3, 2, 11 , 2 , 3
13:39 27F-pm03S
1, 1, 1, 1, 2, 3, 3, 3, 1, 11 , 2 , 3
13:51 27F-pm04 FOXA1CCL4
1, 1, 1, 11
14:03 27F-pm05S -
1, 1, 2, 2, 11 , 2
14:15 27F-pm06S
1, 1, 11

14:27 27F-pm07
1,2, 3, 2, 4, 4, 41 , 2 , 3 , 4
14:39 27F-pm08
1, 2, 2, 2, 21 , 2
14:51 27F-pm09
11
15:03 27F-pm10 (Q)SAR
1, 2, 1, 2
1 , 2
15:15 27F-pm11
1, 2, 11 , 2
15:27 27F-pm12

15:39 27F-pm13S NASH
1, 1, 1, 1, 11
15:51 27F-pm14
1, 1, 1, 1, 2, 11 , 2
16:03 27F-pm15 NO2
-/NO3 -
1, 1, 1, 1, 1, 1, 1, 1, 11
16:15 27F-pm16
1, 2, 3,4, 3, 2, 11 , 2 , 3 , 4
16:27 27F-pm17
1, 1, 1, 1, 1, 2, 11 , 2
– 104 –
3 25 F 3F 8

9:00 25F-am01S Box-Behnken
1, 1, 2, 1, 1, 3, 11 , 2 , 3
9:12 25F-am02S
1, 1, 2, 1, 1, 3, 11 , 2 , 3
9:24 25F-am03 1H-NMR
1, 1, 1, 1, 1, 11
9:36 25F-am04 1H-NMR 2
1, 1, 1, 1, 1, 11
9:48 25F-am05
1, 1, 1, 1, 11
10:00 25F-am06S -
(Exceval) - 1, 1, 2, 2, 2, 11 , 2
10:12 25F-am07
1, 2, 1, 1
1 , 2
10:24 25F-am08S -
- 1, 1, 11
10:36 25F-am09 Eudragit
1, 1, 11
10:48 25F-am10
1, 1, Boonchoo SRITULARAK2, Kittisak LIKHITWITAYAWUID2, 11 , 2
11:00 25F-am11S
1, 1, Samir MITRAGOTRI2, 1, 11 , 2
11:12 25F-am12
1, 1, 2, 2, 1,3, 1, 3, 41 , 2, 3, 4
11:24 25F-am13 OD
1, 1, 1, 1, 2, 1, 1, 1, 11 , 2
3 25 F 3F 8

13:15 25F-pm01S 2
MGAT2DGAT1 1, 1, 1, 1, 1, 1, 1, 1
1
13:27 25F-pm02S 2
MGAT2 DGAT1 1, 1, 1, 1, 1, 1, 1, 1, 11
13:39 25F-pm03S
1, 1, 1, 1, 1, 1, 1, 1
1
13:51 25F-pm04 βHIT-T15
1, 3, 2, 1,2, 1, 4, 1,21 , 2 , 3 , 4
14:03 25F-pm05 (2)
1, 2, 11 , 2
14:15 25F-pm06 γ - in vitro
1, 1, 1, 1, 1, 1, 11

14:27 25F-pm07 Glucose-6-phosphate isomerase peptide (GPI325-339)
fingolimod (FTY720) - - 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 11 , 2 IFReC, 3
14:39 25F-pm08S P- MAPK
1,2, 1, 2, 1, 1, 1, 1, 11 , 2
14:51 25F-pm09
1, 2, 1, 2, 1,21 , 2
15:03 25F-pm10
1, 1, 11
15:15 25F-pm11S HLA
in silico 1, 1, 2, 1, 1, 2, 1, 2, 1
1 , 2
– 105 –
15:27 25F-pm12 RET
1, 1, 1, 1, 1, 1, 2, 1
1 , 2

15:39 25F-pm13S RLE/Abca3
1, 1, 1, 1
1
15:51 25F-pm14
1, 1, 1,2, 3, 1,21 , 2 DDS , 3
16:03 25F-pm15
Mdr1a Bcrp 1, 4, 3, 4, 4, 2,1,31 , 2 , 3 , 4
16:15 25F-pm16
1,2, 1, 3, 1,2, 1, 2, 2,1, 2, 1,2, 2, Feng LI4, JC JENNETTE4, 4, Ananth KARUMANCHI5, Oliver SMITHIES4
1 , 2 , 3 , 4Univ NC, 5Harvard U
16:27 25F-pm17S I
1, 1, 1, 1, 1, 1, 11
3 25 H 1F 1

9:00 25H-am01
1, 1, 1,2, 3, 4, 1,21 , 2 DDS, 3 , 4
9:12 25H-am02 Flash nano-precipitation
Cyclosporine A 1, 1, 1, Wong JENNIFER2, Chan HAK-KIM2, Prud'homme ROBERT K.3, 1, 11 , 2 , 3
9:24 25H-am03
1, 1,3, 1,2,3,4, 5, 1,21 , 2 CMS, 3 , 4 , 5
9:36 25H-am04S
1, 1, Johan UNGA1, 1, 1, 1,2, 1, 1, 11 , 2 PD
9:48 25H-am05S
1, 1, 2, 2, 11 , 2
10:00 25H-am06
1, 1, 1, 1, 11
DDS
10:12 25H-am07S Ad
B 1, 1, 1, 1,2,3
1 , 2 , 3 MEI
10:24 25H-am08S
1, 1, 1, 1, 1, Johan UNGA1, 1, 1, 1, 1, 2, 11 , 2MU
10:36 25H-am09 siRNA
B 1, 1, 1, 1
1
10:48 25H-am10S siRNADOP-DETA
1, 1, 1, 2, 1
1 , 2
11:00 25H-am11S siRNA
1, 1, 1, 2, 1, 11 , 2
11:12 25H-am12 siRNA
1, 1, 1, 1
1
11:24 25H-am13 siRNA
1, 1, 1, 1
1

13:15 25H-pm01 -
- 1, 1, 11
13:27 25H-pm02
1, 2, 11 , 2
13:39 25H-pm03
1, 2, 1, 21 , 2
13:51 25H-pm04
2 1, 11
14:03 25H-pm05
1, 2, 2, 1, 3, 11 , 2 , 3
– 106 –
14:15 25H-pm06
1,3, 2, 2, 3, 1, 4,5, 1,3,51, 2 , 3 , 4 , 5

14:27 25H-pm07
1, 2, 1, 1, 1, 1, 3, 1, 31 , 2 , 3
14:39 25H-pm08 OATPs
1, 1, 11
14:51 25H-pm09
1, 1, 1, 1, 11
15:03 25H-pm10
1,2, 1, 1, 1,2
1 , 2
15:15 25H-pm11 AMR
1,2, 1,2, 1, 1, 1, 2, 2, 2, 11 , 2
15:27 25H-pm12S
1, 1, 1, 1, 1,3, 2, 2, 2, 2, 11 , 2 , 3

15:39 25H-pm13
1, 1, 1, 2, 11 , 2
15:51 25H-pm14
1, 1, 1, 2, 11 , 2
16:03 25H-pm15S Multi-inlet vortex
mixer Cyclosporine A 1, Hoang D. LU2, 1, 1, 1, Robert K. PRUD'HOMME2, 1
1 , 2Princeton
16:15 25H-pm16
1, 1, 1, 11
16:27 25H-pm17S
1, 2, 1,21 , 2
3 25 I 1F 2

9:00 25I-am01S
1, 1, 1, 1, 1, 1, 11
9:12 25I-am02S
1, 1, 1, 1, 1, 1, 11
9:24 25I-am03S iPS
1, 2, 1,2, 3, 1,21, 2, 3
9:36 25I-am04
1, 2, 2, 2, 21 , 2
9:48 25I-am05 CYP2J2
1,2, 1,2, 3, 2, 1,21 , 2 , 3
10:00 25I-am06
cytochrome P 450CYP3A 1, 1, 1, 1, 1, 1, 1, 1, 2, 11 , 2

10:12 25I-am07
1, 2, 2, 2,3, 3, 3, 3, 3, 3, 4, 5, 1,2
1 , 2 , 3ADEKA , 4 , 5
10:24 25I-am08 TR-FRET CLDN-4 binder
1, 1, 1, 1, 1, 11
10:36 25I-am09
1, 1, 1, 1, 1, 2, 2, 3, 3, 3,4, 3, 11 , 2 , 3 , 4

10:48 25I-am10
1, 1, 2, 3, 11 , 2 , 3
11:00 25I-am11
1, 1, 1, 1, 1, 1, 1, 11
– 107 –
11:12 25I-am12 Homoharringtonine
1, 1, 2, 1, 2, 11 , 2
11:24 25I-am13
1, 1, Kadhum W. R.1, 1, 1, 2, 31 , 2 , 3
3 25 I 1F 2

13:15 25I-pm01S
1, 1, 2, 2, 2, 3, 3, 3, 1, 1, 11 , 2 , 3
13:27 25I-pm02S
1, 2, 1, 1, 3, 3, 1, 1, 1,21 , 2 , 3
13:39 25I-pm03
1, 1, 1, 1
1
13:51 25I-pm04S D-Luciferin
bioluminescence 1, 2, 1, 1, 2, 1, 11 , 2
14:03 25I-pm05
1,2, 1, 1, 1, 1, 1, 1, 2, 2, 11 , 2

14:15 25I-pm06S
pH 1, 2, 2, 2, 21 , 2
14:27 25I-pm07S P-gp
1, 2, 3, 1, 1, 11 , 2 , 3
14:39 25I-pm08S
CES Caco-2 1, 1,2, 3, 3, 4, 1, 11 , 2 , 3 , 4
14:51 25I-pm09
1, 1, 1, 1, 11
15:03 25I-pm10 3, 5, 6, 7, 8, 3’, 4’-heptamethoxyflavone
1, 1, 1,2, 1, 1, 11 , 2
15:15 25I-pm11S
1, 1, 1, 1
1

15:27 25I-pm12S Coenzyme Q10
1, 1, 2, 2, 3, 21 , 2 , 3MORESCO
15:39 25I-pm13S
1, 1, 1, 1, 2, 11 , 2
15:51 25I-pm14
16:03 25I-pm15S lutein
1, 1, 1, 1, 11
16:15 25I-pm16S Itraconazole
1, 1, Hoang D. LU2, 1, 1, 1, Robert K. PRUD’HOMME2, 11 , 2Princeton
16:27 25I-pm17 ( )
1, 1, 1, 2, 2, 2, 11 , 2FANCL
3 26 F 3F 8

9:00 26F-am01S
1, 1, 1, 1
1
9:12 26F-am02S /
PD-1/PD-L1 1, 1, 11
9:24 26F-am03S
PD-1PD-L1CTLA-4 1,2, 1,2, Jason LIN1, 1, 1,2, 1, 1, 1, 1,21 , 2
9:36 26F-am04S
1, 1, 1, 1
1
9:48 26F-am05
1, 1, 1, 2, 1, 2, 11 , 2
– 108 –
10:00 26F-am06 5-FU
1, 1, 2, 3, 1, 1, 1, 4, 5,6, 7, 1, 1, 1, 11 , 2 , 3 , 4 , 5 , 6 , 7

10:12 26F-am07 BCL2A1
1, 2, 2, 2, 2, 2, 1, 1, 2, 2, 2,11 , 2
10:24 26F-am08 2 3MCF-7
As2S2 1,2, 1, 1, 3, 4, 1, 1, 1, 11 , 2 , 3 , 4
10:36 26F-am09
1, 1, 1, 1, 11
10:48 26F-am10S C
1, 1, 1, 1, 1,2, 3, 1,21 , 2 RIST TR , 3
11:00 26F-am11 E
1, 1, 11
11:12 26F-am12
1, 1, 1, 1, 1, 1, 1, 4, 1, 1,2,31 , 2 , 3 , 4
11:24 26F-am13 365 24
1, 1, 1, 1, 11
3 26 F 3F 8

13:15 26F-pm01
1, 1, 1, 1, 2, 31 , 2 , 3
13:27 26F-pm02
1, 1, 1, 1, 1, 21 , 2
13:39 26F-pm03
1, 1, 3, 4, 5, 6, 21 , 2 , 3 , 4 , 5 , 6
13:51 26F-pm04
1, 2, 11 , 2
14:03 26F-pm05
14:15 26F-pm06
1, 1, 2, 3, 41 , 2 , 3 , 4

14:27 26F-pm07S
1, 1, 11
14:39 26F-pm08S
1, 1, 11
14:51 26F-pm09
1,2, 2,3, 2,3, 3, 3, 2,31 , 2 , 3
15:03 26F-pm10 PBPM
1, 1, 2, 3, 2, 11 , 2 , 3
15:15 26F-pm11
1, 2, 3, 4, 5, 5, 5, 5, 51 , 2 , 3 , 4 , 5
15:27 26F-pm12

15:39 26F-pm13
1, 1, 1, 1, 1, 11
15:51 26F-pm14 OTC
1, 2, 3, 4, 1, 2, 3, 1, 1, 1, 1, 11 , 2, 3, 4
16:03 26F-pm15
1, 1, 1, 1, 1, 1, 1, 1, 1, 11
16:15 26F-pm16S
1, 1, 1, 1, 11
– 109 –
16:27 26F-pm17
1, 1, 1, 1, 1, 1, 2, 2, 11 , 2
3 26 H 1F 1

9:00 26H-am01 pirfenidone
1, 1, Sharon LEUNG2, 1, Hak-Kim CHAN2, 11, 2
9:12 26H-am02
1, 2, 3, 1, 2, 11 , 2 , 3
9:24 26H-am03
1, 1, 1, 2, 11 , 2
9:36 26H-am04
1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 11

9:48 26H-am05
1, 2, 3, 1, 2, 3, 11 , 2 , 3
10:00 26H-am06 ®
1, 2, 2, 1, 1, 2, 1,2, 2, 2, 2, 3, 1,21 , 2 , 3
10:12 26H-am07 BRS-A
ACP215 1, 1, 1, 1, 1, 1, 2, 11 , 2
10:24 26H-am08
1, 21 , 2 ( )
TDM
10:36 26H-am09 LC-MS/MS
1, 1, 1, 1, 1, 1, 11
10:48 26H-am10S
1, 1, 11
11:00 26H-am11
1,2, 1,2, 1,2, 2, 1,2, 2, 3, 21 , 2 , 3
11:12 26H-am12S
TDM 1,2, 1,2, 4, 3, 1,21 , 2 , 3 , 4
11:24 26H-am13S TDM
1, 1, 1, 2, 2, 3, 4, 41 , 2 ( ), 3 , 4
3 26 H 1F 1

13:15 26H-pm01S
1, 1, 1, 1
1
13:27 26H-pm02S HPLC
1, 1, 1, 1, 2, 2, 2, 1, 11 , 2
13:39 26H-pm03
1,2, 3, 1, 4, 21 , 2 , 3 , 4
13:51 26H-pm04
1, 1, 1, 11
14:03 26H-pm05S LDL-
- 1, 1, 1, 1, 1, 1, 1, 1, 2, 11 , 2
14:15 26H-pm06 non-HDL-
- 1, 1, 1, 1, 1, 1, 1, 1, 1, 21 , 2

14:27 26H-pm07
K 1, 1, 1, 1, 11
14:39 26H-pm08 NVAFDirect
Oral AnticoagulantsDOACsRivaroxaban vs Apixaban 1, 1, 1, 1, 1, 1, 11
– 110 –
14:51 26H-pm09 Carbapenem
1,2, 1, 1, 1,2, 1, 1, 1,2, 1, 1, 1,21 , 2
15:03 26H-pm10S
1, 1, 1, 1, 1, 11
15:15 26H-pm11S
1, 1, 1, 1, 1, 11
15:27 26H-pm12S
1, 1, 1, 1, 1, 11

15:39 26H-pm13
1, 1, 1, 1, 1, 1, 1, 11
15:51 26H-pm14 NKCP
1,2,3, 1, 1, 1, 1, 1, 1,2,3, 2, 4, 2, 2, 1,2,31 , 2 , 3 , 4
26H-pm15
16:03 26H-pm16 75
1, 1, 1, 1, 2, 11 , 2
16:15 26H-pm17
1, 1, 1, 1, 1, 11
3 26 I 1F 2

9:00 26I-am01 P-gp
1, 1, 11
9:12 26I-am02S HIF-1
GLUT1 BCRP PPARγ 1, 1, 1, 1, 1, 11
9:24 26I-am03S
HIF-1 GULT 1, 1, 1, 1, 11
9:36 26I-am04 OATP4C1
1, 1,2, 2, 2,3, 1,21 , 2 , 3
9:48 26I-am05S OATP1B1 OATP1B3
1, 1,2, 2, 2, 1,21 , 2
10:00 26I-am06 OATP2A1/SLCO2A1
1, 1, 1, 1
1

10:12 26I-am07S JEG-3
1, 1, 2, 2, 1, 1,21 , 2
10:24 26I-am08S
1, 1, 1, 1
1
10:36 26I-am09S Hypotaurine
1, 1, 1, 11
10:48 26I-am10S
oat1, oat3 1, 1, 1, 1, 11
11:00 26I-am11S
oatp1a4 1, 1, 1, 1, 11
11:12 26I-am12S hCMEC/D3
exosome 1, 1, 1, 1
1
11:24 26I-am13S SWATH
1, 1, 1, 1, 11
3 26 I 1F 2
ADME, PK/PD
13:15 26I-pm01 MDCKH+/
1, 1, 1, 1
1
13:27 26I-pm02 B
1, 1, 1, 1,2, 3, 3,4,5, 1,21 , 2 DDS , 3 , 4NIH, 5
13:39 26I-pm03
1, 2, 1, 1, 11 , 2
13:51 26I-pm04S
1, 1, 1, 1, 1, 1, 1, 11
– 111 –
14:03 26I-pm05S UFT /
1, 1, 1, 1, 1, 1, 11
ADME, PK/PD
14:15 26I-pm06S SGLT2
1, 1, 1, 1
1
14:27 26I-pm07S SGLT2 ipagliflozin
1, 1, 1, 1, 11
14:39 26I-pm08S
1, 1, 1, 1, 11
14:51 26I-pm09S MRSA
1, 1, 1, 1
1
15:03 26I-pm10S
CKD 1, 2, 2, 2, 3, 1,2, 21 , 2 , 3
15:15 26I-pm11
1, 1, 1, 1, 11
15:27 26I-pm12 CYP
1, 1, 1, 1, 1, 11
15:39 26I-pm13
15:51 26I-pm14
1, 1, 1, 1, 1, 1, 1, 1, 11( )

16:03 26I-pm15
1,2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 2, 1
1 , 2
16:15 26I-pm16
1, 1, 1, 1, 1, 11
16:27 26I-pm17
1, 1, 1, 1, 2, 2, 3, 3, 11, 2, 3
3 27 H 1F 1

9:00 27H-am01S HIF-1 α
1, 1, 1,2,3, 1
1 , 2 , 3 MEI
9:12 27H-am02S HIF-1 α
1, 1, 1, 1,2, 1,2, 2, 11 , 2
9:24 27H-am03 RANK/RANKL
1, 1, 1, 1,2, 1,2, 2, 11 , 2
9:36 27H-am04 GMCF-7
insulin-like growth factor-1 receptor 1, 11
9:48 27H-am05S
in vivo 1, 1, 1, 1, 11
10:00 27H-am06 3D
1, 2, 3, 4, 4, 1, 11 , 2 , 3 , 4

10:12 27H-am07S N-Myc
1, 1, 1, 1, 1,2, 3, 3, 1,21 , 2 RIST TR , 3
10:24 27H-am08S HMGB1/RAGE
1, 1,2, 1, 3, 3, 3, 4, 1,21 , 2 , 3 , 4
10:36 27H-am09
1,2, 1, 1, Mark KESTER3, 1,21 , 2 , 3
10:48 27H-am10S
H2AX 1,2,3, 1,3, 3, 1,3, 2,41 , 2 , 3 , 4
11:00 27H-am11S MST-312
1,2, 1, 3, 2, 11 , 2 , 3
– 112 –
11:12 27H-am12S NF- κ Bmangiferin
1, 1, 1, 1, 1, 1,2, 21, 2
11:24 27H-am13 NIKmangiferin
1, 1, 1, 1,2, 2, 11 , 2
3 27 H 1F 1
27H-pm01
13:15 27H-pm02S azurocidin
1, 1, 2, 3, 1, 1, 3, 1
1 , 2 , 3
13:27 27H-pm03S TGF- β 1 EMT
fad104 1, 1, 1, 11
13:39 27H-pm04S side population
1, 1, 1, 1, 11
13:51 27H-pm05S PKCα Pim-1L
1, 1, 1, 1
1
14:03 27H-pm06 HSP90 quizartinib
1, 1, 1, 1, 11
27H-pm07
14:15 27H-pm08S KSHV RTA IL-10
Sp3 1, 1, 1, 1
1
14:27 27H-pm09 microRNA-133b
PTBP1 PAX3-FOXO1 Warburg 1, 1, 1, 2, 2, 2, 11 , 2
14:39 27H-pm10S
SRSF3 1, 1, 1, 11
14:51 27H-pm11
1, 2, 3, 4, 51 , 2 , 3 , 4 , 5
15:03 27H-pm12S β
1, 1, 1, 1, 11
15:15 27H-pm13S
1, 1, 1, 1, 1, 1, 2,3,4, 1
1 , 2 , 3 , 4 MEI

15:27 27H-pm14S FOXA2
iPS 1, 1,2,3,4, 1, 1,4,5
1 , 2JST , 3 , 4 , 5 MEI
15:39 27H-pm15S iPS DNMT3B
1, 1,2,3,4, 1, 1,3,5
1 , 2 , 3 , 4JST , 5 MEI
15:51 27H-pm16S iPS
1, 1,2,3,4, 1, 1,3,5
1 , 2 , 3 , 4JST , 5 MEI
16:03 27H-pm17S iPS
1, 2,3,4,5, 1,2, 1,2,4,6
1 , 2 , 3 , 4 , 5JST , 6 MEI
3 27 I 1F 2

9:00 27I-am01 L-
(R) 1, 1, 1, 1, 11
9:12 27I-am02 PPARα
1, 1, 1, 1, 1, 1, 1, 2, 2, 3, 11 , 2 , 3
9:24 27I-am03 ES/iPS
1,2,3,4, 1, 1, 1,4,5
1 , 2JST , 3 , 4 , 5 MEI
9:36 27I-am04S β
1, 1, 1, 1, 1, 1, 11
9:48 27I-am05
1, 2, 2, 1
1 , 2
10:00 27I-am06 Caspase-1
1, 1, 1,2, 1
1 , 2

10:12 27I-am07S
1, 1, 1, 1, 1, 1, 11
10:24 27I-am08 SOD1
1, 2, 2, 3, 3, 4, 11 , 2 , 3 , 4
10:36 27I-am09 TDP-43 proteinopathy
1, 1, 1,2, 1, 1, 1, 11 , 2
10:48 27I-am10
1,2, 2, 2, 2, 3, 1,2, 1,2, 4, 2, 21 , 2 , 3 , 4
11:00 27I-am11S sFlt-1
1, 1,2, 1, 1, 3, 2, 2, 1,2, 1,21 , 2 , 3
11:12 27I-am12S
1, 2, 1,3, 2, 3, 1,31 , 2 , 3
11:24 27I-am13S 2
1, 2, 1, 1,3, 1,3, 3, 1,31 , 2 , 3
3 27 I 1F 2

13:15 27I-pm01S Tissue factor
DDS 1, 1, 1, 1,2, 3, 11 , 2 , 3
13:27 27I-pm02
1, 1, 1, 11
13:39 27I-pm03S
1, 1, 1, 11
13:51 27I-pm04
1, 1, 11
14:03 27I-pm05
1, 1, 1, 1
1
14:15 27I-pm06 DDS
1, 1, 1, 1, 1, 11
DDS
14:27 27I-pm07S KALA
1, 1,2, 2, 2, 11 , 2
14:39 27I-pm08
1, 1,2, 1, 2, 2, 2, 2, 2, 1
1 , 2 )
14:51 27I-pm09S Eg5
1, 1,2, 1, 1, 1, 3, 3, 11 , 2 , 3
15:03 27I-pm10S HIF-1 α
1, 1,2, 1, 1, 1, 3, 3, 11 , 2 , 3
15:15 27I-pm11S
PEG 1, 1, 1, 1, 11
15:27 27I-pm12S ThermoDox
1, 1, 2, 2, 2, Nicholas ANDERSON3, 11 , 2 , 3Celsion Corporation
DDS
15:39 27I-pm13 PET
64Cu 1, 1, 1, 2, 11 CLST , 2 CLST
15:51 27I-pm14 DNA
1, 1, 1, 1
1
16:03 27I-pm15S
1, 1, 1,2, 3, 11 , 2 , 3
16:15 27I-pm16
DDS 1, 2, 3, 2, 11 , 2 , 3
16:27 27I-pm17S
siRNA 1, 1, 1, 2, 11 , 2
– 114 –
3 27 E 3F 2

13:15 27E-pm01
1, 1, 1, 1, 1, 1, 1, 1
1
13:27 27E-pm02
1, 1, 1, 1, 1, 11
13:39 27E-pm03
1, 1, 1, 1, 11
13:51 27E-pm04
1, 2, 3
1 , 2 , 3
14:03 27E-pm05
6 1, 1, 1, 1, 1, 1, 1, 2, 2, 11 , 2

14:15 27E-pm06
- - 1,2, 1, 1,2, 1, 1,2, 1,3, 1, 4, 11 , 2 , 3 , 4
14:27 27E-pm07 - -
- ” ” - 1,2, 1, 1, 1,3, 1,2, 1,3, 11 , 2 , 3
14:39 27E-pm08 - -
1,2, 1, 1, 1,3, 4,3, 1,2, 4, 11 , 2 , 3 , 4
14:51 27E-pm09
1, 1, 1, 1,2, 1, 1, 1,21 , 2
15:03 27E-pm10
1 1, 2, 2, 1,2, 1,3, 1, 1, 2, 2, 1,3, 1,2, 11 , 2 , 3

15:15 27E-pm11 ISCE
1, 1, 1, 1, 1, 1, 1, 1
1
15:27 27E-pm12
1, 2, 1, 1, 3, 2, 11 , 2 , 3
15:39 27E-pm13
1, 1, 11
15:51 27E-pm14